Special Issue: Pancreatitis
Oral frailty has been recently suggested as a novel construct defined as a decrease in oral function with a coexisting decline in cognitive and physical functions, which is associated with many adverse events in older adults, such as frailty, sarcopenia, disability, and mortality. We reviewed the definition, symptoms, diagnosis criteria, assessment tools of oral frailty in older people, and summarized its recent research status as well as possible influencing factors, then suggested that future research on oral frailty in older Chinese adults could be carried out in aspects involving developing oral frailty assessment tools appropriate for older Chinese people, implementing survey studies on oral frailty, enriching study designs and contents and enhancing oral frailty intervention studies.
Developmental Trajectory of Frailty in Chinese Elderly People:an Analysis Based on the Latent Growth Model
Frailty is a prominent manifestation of aging. Frailty in Chinese older people has been studied mostly using cross-sectional designs, but its developmental trajectory has been rarely studied using longitudinal designs.
To examine the developmental trajectory and associated factors of frailty in Chinese older people using the data of four national waves of China Health and Retirement Longitudinal Study (CHARLS) .
The data of this study obtained from four national waves〔2011 (the baseline survey), and 2013, 2015 and 2018 (follow-up surveys) 〕 of CHARLS, which was initially conducted in 2011, and was followed by tracking once every 2 to 3 years with multi-stage PPS sampling for middle-aged and elderly groups in 28 provincial administrative regions of China, covering 150 counties and 450 villages. The surveyees were coded, and matched, then 2 267 cases (≥60 years old) involved in the four waves of surveys were selected as the sample. Frailty was assessed by the frailty index (FI). Mplus was used to construct three types of unconditional latent growth models, and the optimal fitting model was selected to determine the developmental trajectory of frailty of Chinese older people, and was used to develop the conditional latent growth model. The effects of time-invariant factors (gender, education level) and time-varying factors (physical activity, smoking, alcohol consumption, sleep) on frailty were examined.
The latent growth model with undefined curve fit the data better, and was selected as the optimal model to determine the frailty development trajectory. The results of χ2 (3) =36.16, CFI=0.992, TLI=0.984, RMSEA=0.070, SRMR=0.022, indicating that the frailty prevalence in older adults showed a trend of curvilinear increase. The values of intercept (initial level), slope (growth), and the variation of them of the model were significantly higher than 0 (P<0.01), indicating that there were significant individual differences in the initial level and growth rate of frailty. Gender and education level were negatively associated with the initial level of frailty (β=-0.113, -0.173, P<0.01). They were also negatively associated with the growth of frailty (β=-0.181, -0.151, P<0.01). Compared with men, women had higher initial level and faster growth rate of frailty (P<0.05). Compared to those with higher education level, those with lower education level had higher initial level and faster growth rate of frailty (P<0.05). Physical activity and sleep were negatively associated with frailty in all waves of surveys (P<0.05). Smoking was positively associated with frailty in 2011, 2015, 2018 waves of surveys (P<0.05). Alcohol consumption was positively associated with frailty in 2013 and 2015 waves of surveys (P<0.05) .
The frailty in Chinese older people showed a trajectory of curvilinear increase, and its initial level and growth rate had significant individual differences. Comparatively speaking, being female and having lower education level were associated with increased risk of having frailty. Moderate- and high-level physical activity and adequate sleep were associated with decreased risk of having frailty or alleviating frailty. Long-term smoking and drinking too much could exacerbate frailty.
Frailty is common in cancer patients, which seriously affects their prognosis. However, the factors associated with frailty in cancer patients are not clear at present.
To identify the factors associated with frailty in cancer patients by a meta-analysis, to provide a scientific basis for the development and implementation of related interventions.
The databases of China National Knowledge Infrastructure (CNKI), CQVIP, WanFang Data, PubMed, Web of Science, Cochrane Library, CINAHL and Embase were comprehensively and systematically searched from inception to August 2022 for included cross-sectional studies, cohort studies or case-control studies reporting associated factors of frailty in cancer patients. Two researchers screened the literature and performed quality evaluation and data extraction. Stata 17.0 and RevMan 5.4 were used for meta-analysis.
Eleven studies were included, among which nine were cross-sectional studies and the other two were cohort studies. Altogether, 2 898 cancer patients were studied, among whom 1 025 were frail, and 12 associated factors of frailty were reported. Meta-analysis showed that the prevalence of frailty in all cancer patients, lung cancer patients, digestive cancer patients, and other cancer patients was 34%〔95%CI (23%, 45%) 〕, 31%〔95%CI (25%, 36%) 〕, 42%〔95%CI (26%, 59%) 〕, and 12%〔95%CI (9%, 16%) 〕, respectively. The risk of frailty in cancer rose with advanced age〔OR=1.16, 95%CI (1.05, 1.27) 〕, combined with other diseases〔OR=1.46, 95%CI (1.28, 1.67) 〕, high BMI〔OR=1.13, 95%CI (1.05, 1.21) 〕, poor nutritional status〔OR=2.77, 95%CI (1.27, 6.06) 〕, high syndrome group scores〔OR=1.07, 95%CI (1.04, 1.09) 〕and depression〔OR=1.27, 95%CI (1.12, 1.44) 〕, but decreased with high education level〔OR=0.78, 95%CI (0.68, 0.90) 〕, albumin level≥35 g/L〔OR=0.33, 95%CI (0.12, 0.90) 〕and high level of instrumental activities of daily living (IADL) 〔OR=0.50, 95%CI (0.42, 0.59) 〕. Egger's test assessing the potential publication bias in 11 studies via funnel plot asymmetry showed that there was a certain publication bias (t=-4.12, P=0.003) .
This meta-analysis revealed that age, education level, comorbidity, BMI, albumin, nutritional status, syndrome group, depression and IADL were the associated factors of frailty in cancer patients. It is necessary for health professionals to pay more attention to cancer patients with advanced age, low education level, combined with other diseases, high BMI, albumin level <35 g/L, poor nutritional status, with syndrome group, depression or low-level activities of daily living, so as to prevent the occurrence of frailty.
Older adults with apathy have a high risk of falls and are prone to repeated falls . Few interventions could achieve satisfactory effects on improving apathy, although improved apathy is associated with a reduced risk of falls. Improving frailty may be a new method for reducing the risk of falls in older adults with apathy.
To investigate the mediating effect of frailty between apathy and risk of falls in older adults in the community, so as to provide a new idea for reducing the fall risk in this group.
A total of 212 community-dwelling older adults were selected to attend a survey by convenience sampling from November 2021 to March 2022, including 128 from Dongshan Community Health Center, Nanjing, and 84 from Qinghu Town, Donghai County, Lianyungang. A self-developed Demographic Information Questionnaire, the Fried Frailty Phenotype (FFP) , Geriatric Depression Scale (GDS-3) , Stopping Elderly Accidents, Deaths & Injuries Tool Kit (STEADI) were used to collect demographics, frailty prevalence, apathy prevalence, and risk of falls, respectively. The intermediary role of frailty in apathy and fall risk was analyzed.
One hundred and ninety-two cases (90.6%) who responded effectively to the survey were included for analysis. The average total STEADI score, average total GDS-3 score, and FFP score of the respondents were 2.0 (0, 4.0) , (1.6±0.9) , and 0 (0, 2.0) , respectively. Fifty-six (29.2%) and other 136 cases (70.8%) were assessed with and without fall risk, respectively. Spearman rank correlation analysis showed that apathy was positively correlated with frailty and fall risk, (rs=0.303, 0.388, P<0.05) , and frailty was positively correlated with fall risk (rs=0.424, P<0.05) . The analysis using intermediary Model 4 showed that apathy had a significant positive effect on fall risk (B=1.011, t=5.207, P<0.05) ; apathy significantly positively influenced frailty (B=0.324, t=3.800, P<0.05) ; frailty had a significant positive effect on fall risk (B=0.679, t=4.173, P<0.05) . Bootstrap test showed that the effect size of frailty in the path of "apathy→frailty→fall risk" was 0.22 〔95%CI (0.08, 0.40) 〕, indicating that frailty played a mediational role between apathy and risk of falls. Apathy could directly affect the fall risk, and could indirectly affect the fall risk through frailty. The total effect was 1.01, in which the size of direct effect was 0.79, the size of mediator effect was 0.22 (accounting for 21.78%) .
Frailty may be a mediator between apathy and fall risk in older adults in the community, and improving frailty is an important way to reduce risk of falling.
Best Evidence Summary for Perioperative Blood Glucose Management in Patients Undergoing Pancreatectomy
Blood glucose disorder is a common perioperative problem in patients with pancreatectomy. However, current perioperative blood glucose management for pancreatic resection patients in China is mostly based on experience and lack of evidence-based basis.
To summarize the best evidence for perioperative blood glucose management in patients undergoing pancreatectomy.
A systematic literature search of BMJ Best Practice, Up to Date, Guideline International Network, International Diabetes Federation, World Health Organization, National Guideline Clearinghouse, American Diabetes Association, the National Institute for Health and Care Excellence, New Zealand Guidelines Group, Canadian Diabetes Association, Australian Diabetes Society, Scottish Intercollegiate Guidelines Network, PubMed, Web of Science, EMBase, CINAHL Database, Cochrane Library, the Joanna Briggs Institute Evidence-based Health Care Center, Medlive.cn, Wanfang Data, CNKI, and Chinese Biomedical Database was conducted to screen the literature on perioperative blood glucose management in patients with pancreatectomy published from inception to December 2020. The AGREE Ⅱ scale updated in 2009 by the International AGREE Collaboration Organization was used to assess the quality of guidelines. The quality assessment of the expert consensus used the 2017 version of the expert consensus evaluation standard of the Australian JBI Evidence-based Health Care Center. The Jadad scale was used to assess the quality of randomized controlled trials (RCTs) .
A total of 6 637 studies were retrieved, and 13 of them were finally included, of which 7 were clinical practice guidelines, 4 were expert consensus, and 2 were RCTs. The results of quality assessment showed that 3 of the 7 clinical practice guidelines were rated grade A, and the remaining 4 were rated grade B. In assessing the quality of the 4 expert consensuses, the answers of raters for all items were "yes" , except that their answers for the item "Is there a reasonable explanation for the point of view inconsistent with other literature?" were "unclear" . Both the two RCTs were rated high. A total of 62 pieces of best evidence were collected, mainly related to perioperative organization and management, admission evaluation and treatment, blood glucose control goals, blood glucose monitoring, preoperative, intraoperative and postoperative blood glucose management strategies, management of emergency conditions, and discharge guidance.
Clinical medical workers can develop individualized and holistic perioperative blood glucose management plans for patients with pancreatectomy, based on the above-mentioned 9 aspects of best evidence.
Cognitive frailty is a cognitive impairment state between normal aging and dementia. Cognitive frailty is associated with higher possibility of negative clinical events than simple frailty or cognitive impairment in older people. As cognitive frailty could be reversible toa certain degree, early identification of high-risk groups and timely intervention are particularly important in reducing adverse prognoses and improving the quality of life of elderly patients in their later years.
To investigate the prevalence and influencing factors of cognitive frailty, and its relationship with two-year post-discharge mortality in hospitalized elderly patients with comorbidities.
The data were collected from part of the project "Research and Demonstration of Clinical Management and Community-based Continuing Care Models for Older People with Comorbidities", involving a cluster sample of older inpatients with comorbidity aged≥60 years recruited from Department of Gerontology, Chengdu Fifth People's Hospital from November 2015 to January 2018. Demographics, chronic disease prevalence, and comprehensive geriatric assessment results were collected. Cognitive frailty was assessed by the FRAIL scale and Mini-Mental State Examination. Binary Logistic regression was used to analyze the influencing factors of cognitive frailty. The survival status was investigated at the end of a two-year follow-up after discharge. Cox regression was used to analyze the relationship of cognitive frailty with two-year post-discharge mortality.
A total of 554 cases were included, and 15.9% (88/554) of them had cognitive frailty. Compared with non-cognitive frailty group, cognitive frailty group had older average age, lower prevalence of high school education or above, lower average family care score, higher prevalence of malnutrition, depression, dependence in activities of daily living and balance dysfunction (P<0.05) . Binary Logistic regression analysis showed that malnutrition, balance dysfunction, and family care disorder were independent factors of cognitive frailty. During the follow-up period, 456 patients (82.3%) survived, 81 (14.6%) died, and 17 (3.1%) were lost to follow-up. After controlling for confounding factors, Cox regression analysis indicated that, the risk of two-year post-discharge mortality in cognitive frailty group was 2.039〔95%CI (1.060, 3.922) 〕times higher than that of those with normal cognitive function and non-frailty, and was 5.266〔95%CI (3.159, 8.778) 〕times higher than that of those with simple cognitive frailty (P<0.05) .
Cognitive frailty is common among elderly inpatients with comorbid conditions, and it can increase the relative risk of two-year post-discharge mortality. Clinical medical workers should pay more attention to this group to identify high-risk individuals of cognitive frailty as soon as possible and give them preventive interventionsin time.
Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have proved to have a certain significance in predicting the severity of pancreatitis, however, at present, there are few relevant studies on the diagnostic and predictive value of NLR and PLR for liver injury in biliary acute pancreatitis (BAP) .
To explore the correlation between NLR and PLR in the severity of BAP and the concurrent acute liver injury (ALI) .
A total of 142 patients with BAP admitted to Emergency Department of the Second Affiliated Hospital of Nanchang University from March 2019 to March 2021 were selected and divided into mild (MAP) /moderately (MSAP) group (n=98) and severe (SAP) group (n=44) according to Atlanta classification. According to whether the liver function is damaged or not, they were divided into ALI group (n=92) and non-ALI group (n=50) . The ALI group was further divided into hepatocyte type liver injury subgroup (n=1) , bile duct type liver injury subgroup (n=16) and mixed type liver injury subgroup (n=75) . The general condition and clinical data of patients were collected, and the predictive value of NLR and PLR on the severity of BAP and concurrent ALI was explored by the ROC curve and binary Logistic regression analysis.
The NLR and PLR in MAP/MSAP group were lower than those in SAP group (P<0.05) . The NLR and PLR in ALI group were higher than those in non-ALI group (P<0.05) . There was no significant difference in NLR and PLR between bile duct type liver injury subgroup and mixed type liver injury subgroup (P>0.05) . The area under the ROC curve of NLR, PLR and their joint prediction of SAP was 0.809, 0.667, 0.809, respectively. The area under the ROC curve of NLR, PLR and their joint prediction of ALI in BAP was 0.774, 0.767, 0.806, respectively. The area under the ROC curve of NLR, PLR and their joint prediction of the occurrence of cholangiocytic liver injury in BAP was 0.813, 0.742, 0.861, respectively. The area under ROC curve of NLR, PLR and their joint prediction of mixed liver injury in BAP was 0.763, 0.770 and 0.794 respectively. The results of binary Logistic regression analysis showed that elevated NLR was a risk factor for SAP〔OR=1.184, 95%CI (1.102, 1.271) , P<0.001〕. Elevated NLR and PLR were the risk factors for ALI in BAP〔OR=1.140, 95%CI (1.050, 1.238) , P=0.002; OR=1.007, 95%CI (1.001, 1.013) , P=0.023〕; elevated NLR was a risk factor for bile duct cell liver injury in BAP〔OR=1.184, 95%CI (1.054, 1.331) , P=0.004〕. Elevated NLR and PLR were risk factors for mixed liver injury in BAP〔OR=1.120, 95%CI (1.120, 1.221) , P=0.011; OR=1.007, 95%CI (1.001, 1.013) , P=0.034〕.
Elevated NLR is a risk factor for SAP, elevated NLR and PLR are the risk factors for ALI in BAP. The predictive value of NLR on the severity of BAP and concurrent ALI is better than PLR, and the combined detection effect is better.
Frailty is a common geriatric syndrome that has become a great public health concern in China with the acceleration of population aging. Hypertension and frailty often coexist in older adults, leading to multiple adverse health outcomes. We reviewed recent advances in epidemiology of frailty in older people with hypertension, and its pathogenesis involving inflammatory response, oxidative stress, insulin resistance and hormone metabolism, and the possible mechanisms of action of exercise in improving it, then summarized that relevant studies on mechanisms of action of exercise in enhancing frailty in older people with hypertension are still insufficient, and the mechanism of action varies by the type of exercise. Further research could explore the targets and effects of different types of exercise in improving frailty in older people with hypertension.
Hypertriglyceridemia has been increasingly valued as a risk factor for acute pancreatitis (AP) . However, the relationship between obesity and AP has not yet been confirmed, whether baseline triglyceride (TG) affects the risk of AP in non-obese people is still inconclusive.
To explore the association between baseline serum triglyceride (TG) and the risk of AP in a nonobese cohort from Kailuan Group.
A prospective cohort study was performed among in-service and retired workers of Kailuan Group (non-obese, without a history of AP, with complete TG information) who first attended the annual health screening for workers of the group as a benefit conducted between 2006 and 2007 or between 2008-2009. The cumulative incidence of AP across serum TG tertile groups: 〔Q1 group (TG≤0.96 mmol/L) , Q2 group (0.96 mmol/L<TG<1.52 mmol/L) , Q3 group (TG≥1.52 mmol/L) 〕was described using Kaplan-Meier curve, and compared by the Log-rank test. The new AP event, death or the end of follow-up (December 31, 2020) was taken as the end point of follow-up. Cox regression model was used to estimate the association of baseline TG levels and new incidence of AP.
The study included a total of 102 358 subjects. Q1, Q2 and Q3 groups had significant differences in sex ratio, average age, systolic blood pressure, diastolic blood pressure, fasting blood glucose, total cholesterol (TC) , low-density lipoprotein cholesterol (LDL-C) , and high-density lipoprotein cholesterol (HDL-C) , and prevalence of smoking, drinking, previous hypertension, previous diabetes, previous cholelithiasis, as well as having at least 9 years of education (P<0.05) . Three hundred and sixteen cases developed AP during an average follow-up of (12.8±2.4) years, with an incidence density of AP of 2.41 per 10 000 person-years. The incidence density was 1.82, 2.22, and 3.17 per 10 000 person-years in Q1, Q2, and Q3 groups, respectively. The cumulative incidence of AP was 2.33%, 2.85% and 4.07%, respectively, in Q1, Q2, and Q3 groups, with statistically differences detected by the log-rank test (χ2=17.27, P<0.001) . By the analysis based on COX regression model 3, the HR of developing AP in Q3 group was 1.66〔95%CI (1.25, 2.19) 〕times higher than in Q1 group after adjusting for sex, age, HDL-C, TC, smoking, drinking, education level, history of hypertension, history of diabetes and history of cholelithiasis, and it was 1.68〔95%CI (1.25, 2.24) 〕times higher than in Q1 group after further excluding the cases suffering from AP within 1 year of follow-up.
A baseline serum TG level of ≥ 1.52 mmol/L may increase the risk of AP in nonobese people.
With the aggravation of population aging in China, the number of elderly perioperative orthopedic patients is increasing, and the growing prevalence of frailty in older patients undergoing orthopedic surgery has attracted increasing attention. Early preoperative assessment and intervention of frailty are of great significance for improving postoperative prognosis and reducing the occurrence of complications in this population.
To perform a scoping review of frailty assessment tools for elderly orthopedic inpatients, and to provide a reference for the selection of frailty assessment tools for this group.
Seven databases (PubMed, CINAHL, PsycINFO, Scopus, Embase, CNKI and Wanfang Data) were searched for studies on frailty assessment tools for older orthopedic inpatients from 2006 to 2021. Two researchers independently screened the literature and extracted the basic characteristics of the literature (the flint author, publication time, country, basic information, research tools and outcome indicators) and the basic characteristics of involved frailty assessment tools (name, study country, study type, scale dimension, number of items, assessment cut-off value, assessment time, etc.) .
A total of 1733 studies were retrieved, and 25 of them with 12 frailty assessment tools were included. The analysis showed that there are a variety of assessment tools, and different studies have used different frailty assessment tools. Frailty Phenotype and Frailty Index are the two common tools. The application of accurate and effective tools for frailty screening is crucial to improving preoperative risk stratification and postoperative prognosis. Frailty assessment using the Reported Edmonton Frail Scale, FRAIL Scale, PRISMA-7 Questionnaire or the Groningen Frailty Index can be completed without the use of additional measuring equipment and surveyors with an experience of training.
The selection of an optimal frailty assessment tool for elderly orthopedic inpatients should be in accordance with patient features, clinical resources and the performance of the tool. However, there is still lack of a gold standard for frailty assessment. Future studies are needed to assess the reliability and validity of existing frailty assessment scales or to develop frailty assessment tools applicable to Chinese older orthopedic inpatients.
As an important modifiable factor that can be intervened, nutrition is closely related to the occurrence of frailty. Early identification of frailty through nutrition evaluation and reversal of its occurrence is of great significance for improving clinical outcomes. There are few available studies on the predictive value of nutrition-related parameters for frailty among older patients in the emergency department (ED) .
To evaluate the relationship between commonly used nutrition-related parameters and frailty among older adults in the ED.
Two hundred and ten people aged≥65 years were recruited from the Department of Emergency Medicine, China Rehabilitation Research Center (Beijing Bo'Ai Hospital) from January to October 2021. The demographic data were recorded. Fasting venous blood sample was collected within 24 hours after admission to measure routine indicators. The nutritional risk was assessed by Nutrition Risk Screening 2002 (NRS2002) . The basic activities of daily living were evaluated by Barthel Index (BI) . The Clinical Frailty Scale (CFS) was used to assess frailty, and individuals with CFS levels 1-4 (n=68) and those with CFS levels 5-9 (n=142) were assigned to non-frail group and frail group, respectively. Multivariable Logistic regression was used to analyze the factors associated with frailty in older patients in the ED. Hosmer-Lemeshow test and receiver operating characteristic (ROC) curve were used to evaluate the predictive validity of nutrition-related parameters for frailty in older patients in the ED. Nonparametric DeLong test was used to compare the area under the ROC curve (AUC) of each parameter.
There were statistically significant differences between frail and non-frail patients in mean age, sex ratio, mean body mass index (BMI) , prevalence of coronary heart disease, mean levels of hemoglobin (HGB) , albumin (ALB) , prealbumin (PA) , high-sensitivity C-reactive protein (hs-CRP) and 25-hydroxyvitamin D〔25 (OH) D〕, and mean score of NRS2002, as well as mean BI and length of hospital stay (P<0.05) . Multivariable Logistic regression analysis showed that higher PA〔OR=0.943, 95%CI (0.891, 0.998) , P=0.041〕 and 25 (OH) D〔OR=0.909, 95%CI (0.844, 0.979) , P=0.012〕were protective factors of frailty in older patients in the ED. The risk of frailty decreased by 44.6% for every 100 mg/L increase in PA, and decreased by 61.7% for every 10 μg/L increase in 25 (OH) D. However, higher NRS2002 score〔OR=1.701, 95%CI (1.353, 2.138) , P<0.001〕was the risk factor of frailty in older patients in the ED, and the risk of frailty increased by 70.1% for every one score increase in NRS2002 score. Hosmer-Lemeshow test showed PA (χ2=6.120, P=0.634) , 25 (OH) D (χ2=5.386, P=0.716) and NRS2002 score (χ2=4.758, P=0.446) had good goodness of fit. ROC analysis demonstrated showed that the optimal cutoff values of PA, 25 (OH) D and NRS2002 score for predicting frailty in older patients in the ED were 211.9 mg/L, 7.06 μg/L and 3 points, respectively, and the AUCs of them were 0.749, 0.670 and 0.835, respectively. Nonparametric DeLong test showed that the AUC of NRS2002 score was greater than that of PA (Z=2.241, P=0.025) and 25 (OH) D (Z=3.400, P<0.001) .
As frail patients have poor nutritional status, nutritional assessment contributes to early identification of frailty. Among the nutrition-related parameters, PA, 25 (OH) D and NRS2002 score can effectively predict frailty in older patients in the ED, and NRS2002 score may have the strongest predictive ability.
Preoperative frailty is a severely unhealthy status that reflects the reduction of overall physiological reserve, which is highly prevalent in elderly patients with gastric cancer. Understanding the perceived influencing factors of preoperative frailty can provide an important basis for developing individualized intervention plans.
To perform a qualitative descriptive study to identity the perceived influencing factors of preoperative frailty among elderly gastric cancer patients using the theory of health ecology.
A qualitative descriptive study was conducted based on health ecology theory. Purposive sampling method was used to select 29 frail elderly patients who would undergo gastric cancer surgery in the First Affiliated Hospital with Nanjing Medical University from February to June 2021 for semi-structured interview. Directed content analysis was used for data analysis.
Five themes and thirteen sub-themes were extracted: physiological traits, including accumulated aging-related losses, obvious gastrointestinal symptoms, and successive attacks of multiple diseases; behavioral characteristics, including lack of exercise behavior and overexertion; interpersonal networks, including insufficient peer social interaction, lack of parent-child interaction, and lack of communication and self-disclosure between couples; living and working conditions, including heavy individual financial burden, heavy unplanned family care tasks, insufficient information resources for health and disease management; macro factors, including limited medical services and medical insurance support.
This study described the effects of different perceived factors on preoperative frailty among elderly gastric cancer patients from the perspective of health ecology. Medical workers should formulate and implement systematic prehabilitation programs based on the above factors to improve the patients' preoperative anti-stress capacity and postoperative outcomes.
Malignant hypertension is a common hypertensive emergency, which generally progresses rapidly, often affects important target organs such as the heart, brain, and kidney, leading to organ insufficiency. Malignant hypertension may develop serious complications, among which thrombotic microangiopathy is mainly characterized by impaired tissue and organ functions due to thrombosis in the microcirculation, with critical condition and poor prognosis generally. Pancreatic involvement in malignant hypertension is rare, whose prognosis may be extreme poor and mortality may be high due to insufficient understanding of it, and lack of clinical evidence on its early diagnosis and treatment. We reported the diagnosis and treatment of a case of acute pancreatic infarction caused by malignant hypertension, aiming at providing a reference for clinical practice.
Acute kidney injury (AKI) is a common complication and a key poor prognostic factor in severe acute pancreatitis (SAP) . It is rather challengeable to prevent and treat AKI in SAP, but early assessment and intervention of related risk factors can prevent or delay its development.
To systematically analyze the risk factors of AKI in SAP.
Databases of PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang Data, CQVIP and SinoMed were searched for articles about the risk factors of AKI in SAP from inception to January 2022. Two researchers independently performed literature screening according to inclusion and exclusion criteria, data extraction, and methodological quality assessment. RevMan 5.4 and Stata 15.1 were employed for Meta-analysis.
In total, 21 studies were included, including 3 823 patients. Meta-analysis demonstrated that being male〔OR=1.42, 95%CI (1.21, 1.68) , P<0.001〕, drinking history〔OR=1.51, 95%CI (1.14, 2.01) , P=0.004], higher APACHE Ⅱ score〔MD=5.69, 95%CI (2.95, 8.44) , P<0.001〕, Ranson score〔MD=2.58, 95%CI (2.27, 2.88) , P<0.001〕, and CTSI score〔MD=1.48, 95%CI (0.17, 2.80) , P=0.030〕; increased lencocyte count〔MD=0.96, 95%CI (0.47, 1.44) , P<0.001〕, IL-33〔MD=28.36, 95%CI (19.05, 37.67) , P<0.001〕, CRP〔MD=17.38, 95%CI (12.39, 22.38) , P<0.001〕, Scr〔MD=49.50, 95%CI (24.80, 74.19) , P<0.001〕, PCT〔MD=6.74, 95%CI (3.36, 10.12) , P<0.001〕, neutrophil gelatinase-associated lipocalin (NGAL) 〔MD=18.31, 95%CI (11.82, 24.80) , P<0.001〕, and serum lactate〔MD=0.87, 95%CI (0.27, 1.46) , P=0.004〕; prevalence of hypoxemia〔OR=9.42, 95%CI (4.81, 18.44) , P<0.001〕, hypertension〔OR=1.35, 95%CI (1.06, 1.72) , P=0.010〕, diabetes〔OR=1.56, 95%CI (1.20, 2.04) , P<0.001〕, and coronary heart disease〔OR=3.20, 95%CI (1.41, 7.24) , P=0.005〕; use of mechanical ventilation〔OR=5.00, 95%CI (2.76, 9.07) , P<0.001〕; prevalence of shock〔OR=11.60, 95%CI (3.37, 39.91) , P<0.001〕, infection〔OR=5.78, 95%CI (3.10, 10.79) , P<0.001〕, multiple organ dysfunction syndrome (MODS) 〔OR=7.28, 95%CI (3.56, 14.88) , P<0.001〕, abdominal bleeding〔OR=5.51, 95%CI (1.38, 22.09) , P=0.020〕, acute respiratory distress syndrome (ARDS) 〔OR=9.61, 95%CI (4.14, 22.27) , P<0.001〕, and abdominal compartment syndrome (ACS) 〔OR=5.79, 95%CI (3.75, 8.93) , P<0.001〕; long stay in the ICU〔MD=8.77, 95%CI (2.76, 14.79) , P=0.004〕were risk factors of AKI in SAP.
Male, drinking history, higher APACHEⅡ score, Ranson score and CTSI score, elevated inflammatory markers (lencocyte count, IL-33, CRP, Scr, PCT, NGAL) and elevated serum lactate, underlying disease prevalence (hypoxemia, hypertension, diabetes, coronary heart disease) , use of mechanical ventilation, prevalence of shock, infection, MODS, abdominal bleeding, ARDS, and ACS, long stay in the ICU may be risk factors for AKI in SAP. Clinical medical workers should early identify and intervene SAP patients with the above-mentioned risks, so as to reduce the incidence of AKI.
As China enters an ageing society, the number of elderly people is rising sharply, resulting in a continuous increase in the cost and burden of caring for the elderly. Frailty is an important cause of loss of self-care ability and elderly care problems in elderly people, which means that frailty is associated with a decline not only in physiological functions, but in multiple areas as well, such as mental ability and socioeconomic functioning, and is considered an important geriatric syndrome that affects the quality of life of the elderly. Comprehensive Geriatric Assessment (CGA) is a multi-dimensional and multi-disciplinary assessment process or model specifically for elderly patients. As a core tool in geriatric medicine, it uses a multi-dimensional and multi-disciplinary approach to assess the physical condition, functional status, mental health and social environment status of the elderly, and accordingly a treatment plan is developed to maintain and improve the functional status of the elderly and enhance their quality of life to the most extent. However, the use of CGA is not entirely consistent in China and abroad. This paper reviews the existing studies on frailty in the elderly, analyses the advantages and shortcomings of CGA used in frail elderly patients, and finds that interventions for frail patients at home and abroad have been valued increasingly. The development of domestic interventional studies on frailty is still in the initial stage, and most of these studies use a design of a randomized controlled trial with a sample of chronic disease inpatients. In contrast, such studies have been widely carried out abroad, in which CGA has been applied to the management of cancer patients and patients in the perioperative period besides chronic disease patients and frail community-dwelling older people. The frailty status in the elderly can be scientifically and comprehensively assessed by the CGA, and based on which targeted interventions can be implemented to prevent or delay the development of frailty, but it is generally time-consuming, and there are many difficulties in the management of the assessment recipients. In the future, it is necessary to advance the clinical application of CGA, or develop a more rapid, comprehensive and authoritative tool based on CGA for frailty assessment in the elderly, so as to provide comprehensive and personalized medical services and health guidance for frail elderly population through standardised assessment.
Frailty can increase the risk of negative health-related outcomes in older adults. Protein supplementation may be an effective way to improve frailty, but there is disagreement about its effects on frailty.
To systematically evaluate the effects of protein supplementation on muscle mass, strength, and physical function in frail/pre-frail older adults.
Electronic databases of CNKI, Wanfang Data, CQVIP, PubMed, Embase, Web of Science, Cochrane Library, CINAHL and Medline were retrieved for randomized controlled trials (RCTs) of the effects of protein supplementation on muscle mass, strength and physical function in frail/pre-frail older adults published from inception to June 2022. After literature screening, the quality of eligible RCTs was evaluated, and from which relevant data were extracted. RevMan 5.4 was performed to explore the effects of protein supplementation on muscle mass, muscle strength and physical function in frail/pre-frail older adults. And for the outcome indicator of muscle strength (grip strength) , due to large amount of reported literature, this study will be based on the amount of protein supplementation (<30 g/d subgroup and≥30 g/d subgroup) , frailty status (pre-frailty subgroup, frailty subgroup, frailty and pre-frailty subgroup) , frailty assessment tool 〔frailty phenotype assessment tool (FP) subgroup and non-FP subgroup〕, population (Asian subgroup and European subgroup) , and mean age (70-<75 years subgroup, 75-<80 years subgroup, and 80-<85 years subgroup) for subgroup analysis to further explore the effect of protein supplementation on grip strength in different subgroups.
A total of 12 RCTs were included (2 literatures for pre-frailty, 3 literatures for frailty, 7 literatures for frailty and pre-frailty) , with a total of 833 older adults (422 in the protein supplementation group and 411 in the control group) . Meta-analysis results showed that protein supplementation improved gait speed in frail/pre-frail older adults〔MD=0.03, 95%CI (0, 0.06) , P=0.05〕, but in improving muscle mass (appendicular lean mass) , muscle strength (grip strength) , other physical functions (assessment results of balance test, the timed up and go test, Short Physical Performance Battery) and frailty scores, the differences were not statistically significant (P>0.05) . The results of subgroup analysis showed that the effect of protein supplementation on the grip strength of the Asian population subgroup was significantly different from that of the European population subgroup in between-group comparisons (χ2=5.76, P=0.02) .
Protein supplementation may improve gait speed in frail/pre-frail older adults, but it does not show a significant advantage in improving their muscle mass, muscle strength and other physical functions. It is recommended to further investigate the effects of longer durations of supplementation, different types of protein supplemented, different amounts of supplementation and different regional populations on older adults with different frailty states, in order to find the best pattern of protein supplementation and provide a more sufficient evidence-based basis for frailty management.
Both frailty and potentially inappropriate medication (PIM) are relatively highly prevalent in adults with mild cognitive impairment (MCI) in the community, but the association of PIM with frailty in MCI population remains to be further explored.
To examine the association between PIM and frailty in older adults with MCI in the community.
This study was conducted between March to July 2021. By use of multistage sampling, older adults with MCI (n=230) were recruited from Baohe District, Hefei City. Sociodemographics, lifestyle indicators and physical functions of the subjects were collected by using the General Information Questionnaire developed by our research team. Frailty was assessed by the Comprehensive Frailty Assessment Instrument. PIM was assessed by the 2017 Criteria of Potentially Inappropriate Medications for Older Adults in China. Logistic regression analysis was applied to analyze the association of the number and types of PIM with frailty.
The prevalence of frailty and PIM in these older adults with MCI was 59.1% (136/230) and 59.1% (136/230) , respectively. The prevalence of PIM in the frailty group was much higher than that of non-frailty group〔80.9% (110/136) vs 27.7% (26/94) 〕 (P<0.05) . Multivariate Logistic regression analysis demonstrated that compared with MCI older adults without PIM, the risk of frailty was 4.591 times higher in those with only one PIM〔95%CI (1.903, 11.076) 〕, and 8.859 times higher in those with two or more PIMs〔95%CI (2.589, 30.321) 〕. Compared with MCI older adults with neurological disease but without PIM, the risk of frailty was 5.310 times higher in those with PIM〔95%CI (1.011, 27.877) 〕. The risk of frailty was 3.108 times higher in those with cardiovascular disease and PIM than that in those without PIM〔95%CI (1.173, 8.241) 〕.
The prevalence of frailty and PIM was higher in older adults with MCI in the community, and PIM was significantly associated with frailty. To decrease the prevalence of frailty and delay the progression of dementia in this population via reducing the prevalence of PIM, community-based health efforts should be made to strengthen the screening for frailty, enhance the identification of frailty related to medication use, and promote medication review and management.
Previous studies have shown that self-rated health would be used as a simple assessment indicator for frailty, and individuals with poor self-rated health status are at higher risk of frailty. However, the association between self-rated health and frailty may be different and the effectiveness of self-rated health in frailty assessment may vary in apathetic older adults.
To explore the moderating role of apathy in the association between self-rated health and frailty among community-dwelling older adults, so as to provide theoretical guidance for the application of the self-rated health in the assessment of frailty in apathetic older adults.
From November 2021 to March 2022, a total of 384 community-dwelling older adults were selected as respondents by convenience sampling method, including 179 cases in Nanjing Dongshan Community and 205 cases in Lianyungang Qinghu Community. Questionnaire surveys were conducted using the General Information Questionnaire, Fried Frailty Phenotyp (FFP) , Geriatric Depression Scale (GDS-3) , and the self-reported health (SRH) . Generalized linear model was used to analyze the association between self-rated health and frailty of community-dwelling older adults. The model 1 of the SPSS macro program process compiled by Hayes was used to analyze the moderating role of apathy on the association between the self-rated health and frailty, with simple slope analyze performed and simple slope graphs plotted.
The median FFP and SRH item scores of 384 community-dwelling older adults were 1.00 (2.00) and 4.00 (1.00) , respectively, with the detection rate of apathy of 55.5% (213/384) . The results of the generalized linear model showed that the relationship between the self-rated health and frailty of community-dwelling older adults was significant (b=0.310, P<0.001) . The results of the moderating effect test showed that apathy played a moderating role in the relationship between self-rated health status and frailty in community-dwelling older adults (b=0.355, t=3.074, P=0.002) , and the results of simple slope analysis showed that the simple slope of the non-apathy group and apathy group was 0.100 (t=1.209, P=0.228) and 0.455 (t=5.206, P<0.001) respectively.
There is an association between self-rated health and frailty in community-dwelling older adults, and the application of the self-rated health can help community health workers assess frailty in older adults. Apathy plays a moderating role in the relationship between self-rated health and frailty. Compared with the non-apathetic older adults, the association between self-rated health and frailty is significant in apathetic older adults. Strengthening the self-rated health assessment of older adults is beneficial to the identification of their frailty.
The somatic symptom clusters may be associated with increased risk of adverse outcomes in frail elderly people. Relevant studies in China have mainly adopted a cross-sectional design with neglect of the trajectory of somatic symptom clusters in this group.
To explore the characteristics of somatic symptom clusters at different time points and influencing factors in elderly people with frailty in nursing homes in Chengdu.
From November 2019 to January 2020, 206 frail elderly people were selected from 6 nursing homes in Chengdu by convenience sampling, and surveyed using the general data questionnaire and Memory Symptom Assessment Scale (MSAS) for 3 times〔at baseline (T0) , 6 (T1) , and 12 months later (T2) 〕. Exploratory factor analysis was carried out for symptoms with an incidence of ≥20% at different time points. Latent growth mixture model (LGMM) was used to identify the change trajectory of somatic symptom clusters across the above-mentioned three time points. Logistic regression analysis was used to identify the potential factors associated with the trajectory category.
By exploratory factor analysis, 5 factors were extracted at each of the three time points. Neurological symptom cluster, energy deficiency symptom cluster, respiratory symptom cluster and digestive symptom cluster all appeared at the three time points. In addition, senescence-related symptom cluster also occurred at T0 and T1, and other symptom cluster occurred at T2. The MSAS score of each symptom cluster differed significantly across three time points (P<0.05) . Four heterogeneous trajectories of frailty symptom clusters were obtained by LGMM model fitting, which were named as "high decline" "low rise" "medium maintenance" and "high rise", accounting for 16.5%, 12.5%, 66.0% and 5.0%, respectively. Multivariate Logistic regression analysis showed that the number of chronic diseases was independently associated with the "high decline" or "high rise" trajectory, and the number of medications was independently associated with the "high rise" trajectory (P<0.05) .
There are various trajectories of somatic symptom clusters in frail elderly people in nursing homes, and each of the trajectories has a different independently associated factor. To provide more appropriate services for this population, medical workers in nursing homes can dynamically adjust nursing services according to the trajectories and associated factors of somatic symptom clusters.
Due to great differences in physiological reserve, psychological status and social functioning, frailty in elderly patients with gastric cancer may present various subtypes. The relationship between preoperative frailty and postoperative adverse outcomes in them still remains to be further explored.
To explore the relationship between preoperative frailty subtypes and postoperative adverse outcomes〔total complications, prolonged length of stay (PLOS), low quality of life (QOL), and disability〕among elderly patients with gastric cancer.
From March to October 2021, 404 elderly gastric cancer patients were selected from Department of Gastric Surgery, the First Affiliated Hospital with Nanjing Medical University by convenience sampling. The General Demographic Data Questionnaire and Tilburg Frailty Indicator were used to collect demographics and frailty status before surgery. Total complications and PLOS were collected from the electronic medical records, and the status of disability and QOL were obtained using a telephone follow-up at one month after discharge. Univariate Logistic regression was performed to explore the influencing factors of postoperative adverse outcomes. Multivariate Logistic regression analysis was performed to analyze the association of preoperative frailty subtypes with postoperative adverse outcomes, with potential confounders adjusted.
Two hundred and eighty-five cases were found with preoperative frailty, and the frailty subtypes in them were classified into eight classes: exclusive physical frailty〔77 (19.1%) 〕, exclusive psychological frailty〔78 (19.3%) 〕, exclusive social frailty〔23 (5.7%) 〕, physical and psychological frailty〔63 (15.6%) 〕, physical and social frailty〔13 (3.2%) 〕, psychological and social frailty〔16 (4.0%) 〕, multidimensional frailty (physical, psychological, and social frailty) 〔15 (3.7%) 〕. The other 119 (29.5%) cases had no preoperative frailty. In the univariate Logistic regression, age was the factor influencing total complications〔OR=1.063, 95%CI (1.021, 1.106), P=0.003〕. History of pharmacological treatment〔OR=1.549, 95%CI (1.016, 2.362), P=0.042〕and surgical approach〔OR=2.103, 95%CI (1.191, 3.712), P=0.010〕were the factors influencing PLOS. Marital status〔OR=4.611, 95%CI (1.079, 19.706), P=0.039〕, living in an urban area〔OR=1.614, 95%CI (1.009, 2.582), P=0.046〕, having at least two comorbidities〔OR=1.694, 95%CI (1.038, 2.766), P=0.035〕were the factors influencing postoperative low QOL. Living in an urban area〔OR=0.601, 95%CI (0.390, 0.926), P=0.021〕, history of pharmacological treatment〔OR=1.663, 95%CI (1.082, 2.558), P=0.020〕, and advanced TNM stages〔OR=1.659, 95%CI (1.017, 2.706), P=0.043〕were the factors influencing postoperative disability. In the multivariate Logistic regression, the preoperative multidimensional frailty was independently associated with total complications, with age adjusted〔OR=5.344, 95%CI (1.715, 16.656), P=0.004〕. The preoperative physical frailty〔OR=2.048, 95%CI (1.078, 3.891), P=0.029〕, preoperative psychological frailty〔OR=2.077, 95%CI (1.103, 3.913), P=0.024〕and preoperative multidimensional frailty〔OR=8.321, 95%CI (2.400, 28.848), P<0.001〕were independently associated with PLOS, with history of pharmacological treatment and surgical approach adjusted. Preoperative psychological frailty〔OR=2.620, 95%CI (1.267, 5.418), P=0.009〕, preoperative psychological and social frailty〔OR=11.122, 95%CI (3.253, 38.028), P<0.001〕and preoperative multidimensional frailty〔OR=11.579, 95%CI (2.835, 47.302), P<0.001〕were independently associated with postoperative low QOL, with marital status, living in an urban area, and having at least two comorbidities adjusted.
Medical professionals should pay attention to preoperative frailty prevalence in elderly gastric cancer patients, and assess preoperative frailty in these patients using tools with the multidimensional frailty scale included, and attach great importance to those with exclusive physical frailty, exclusive psychological frailty, psychological and social frailty, and multidimensional frailty before surgery. A targeted prerehabilitation intervention program can be delivered to those with preoperative frailty according to their subtypes of frailty to improve postoperative adverse outcomes and QOL.
At present, there are few intervention studies on cognitive frailty in elderly diabetic patients. This study aims to explore the application effect of Baduanjin combined with cognitive training in elderly diabetic patients with cognitive frailty, in order to provide reference for the management of this population.
To explore the intervention effect of Baduanjin combined with cognitive training on elderly diabetic patients with cognitive frailty.
A total of 84 elderly diabetic patients with cognitive frailty hospitalized in the Department of Endocrinology, Shanxi Provincial People's Hospital from October 2021 to April 2022 were selected as research subjects by convenient sampling method, and randomly divided into the experimental group (n=42) and the control group (n=42) according to the random number table method. The patients in the experimental group received Baduanjin exercise combined with cognitive training, 3 times per week for 12 weeks; patients in the control group were given routine exercise and health education. General data of the patients were collected, including gender, age, education level, marital status, residential status, personal monthly income, type of medical insurance and number of comorbid chronic diseases. The Montreal Cognitive Assessment (MoCA) score, Frailty Phenotype (FP) score, gait speed, grip strength and glycated hemoglobin A1c (HbA1c) were compared at baseline, 6 weeks and 12 weeks of intervention between the two groups.
During the study period, 3 cases were lost to follow-up in the control group and 2 cases were lost in the experimental group, a total of 79 patients were finally included (39 cases in the control group and 40 cases in the experimental group) . There was no significant difference in the general data between the two groups (P>0.05) . There were interaction effects of group and time on MoCA score, FP score, gait speed and grip strength (P<0.05) . MoCA score of patients in the experimental group was higher than that in the control group at 12 weeks of intervention (P<0.05) , and higher than that at baseline and 6 weeks of intervention (P<0.05) . FP score of patients in the experimental group was lower than that in the control group at 12 weeks of intervention, and lower than that at baseline and 6 weeks of intervention (P<0.05) . Gait speed and grip strength of patients in the experimental group were higher than those in the control group at 12 weeks of intervention, and higher than those at baseline and 6 weeks of intervention (P<0.05) . HbA1c level of patients in the experimental group was lower than that in the control group, and lower than that at baseline at 12 weeks of intervention (P<0.05) .
Baduanjin combined with cognitive training can slow down the decline of cognitive function in elderly diabetic patients, improve physical frailty and reduce the blood glucose level of patients, which is suitable for vigorously promoting in the clinical and community settings.
Early diagnosis of frailty is of great value in helping the elderly to regain their health, as it is a non-specific state of reduced physiological reserve, resistance to disease and ability to recover from stress caused by the impairment in homeostasis maintained by multiple systems with sarcopenia as the basic characteristic. Recent developments in multiomic techniques provide new approaches to the detection of potentially specific, stable and reliable biomarkers of pre-frailty. We collected and reviewed recent advances in multiomic techniques for identifying frailty biomarkers, involving genomics, transcriptomics, proteomics and metabolomics, which can assist in assessing the risk of frailty, exploring potential mechanisms of frailty and developing targeted interventions to support healthy aging.
Acute pancreatitis (AP) is a common acute abdominal abdomen, and severe AP has considerable mortality. Early and accurate identification of AP is critical for the prevention, treatment and prognosis evaluation of AP. Studies have shown that obesity is associated with the incidence and clinical outcome of AP. However, there is a lack of obesity-related quantitative indices for the diagnosis and evaluation of AP.
To investigate the relationship of abdominal fat content and distribution with AP and its severity, providing a scientific basis for the prevention, diagnosis and treatment of AP.
One hundred AP patients (including 75 with non-severe AP and 25 with severe AP) and 100 non-AP patients〔AP was diagnosed by Chinese Guidelines for the Management of Acute Pancreatitis (Shenyang, 2019) 〕were selected from Department of General Surgery, the Southwest Hospital of AMU from January 2019 to June 2021. Clinical data were collected, including sex, age, underlying disease (hypertension, diabetes or hyperlipidemia) , history of biliary tract disease, BMI, areas of CT-assessed abdominal subcutaneous adipose tissue (SAT) , visceral adipose tissue (VAT) and total abdominal adipose tissue (TAT) , and calculated VAT/SAT ratio and VAT/TAT ratio. Multivariate Logistic regression analysis was conducted to identify factors associated with AP and its severity. ROC analysis was conducted to estimate the diagnostic value and efficiency of BMI, and indices related to abdominal fat content and distribution for the prevalence and severity of AP.
The proportion of BMI and hyperlipidemia in AP group was higher than that in non-AP group (P<0.05) . VAT, TAT, VAT/SAT and VAT/TAT in AP group were higher than those in non-AP group (P<0.05) . VAT, TAT, VAT/SAT and VAT/TAT in severe AP subgroup were higher than those in non-severe AP subgroup (P<0.05) . Multivariate Logistic analysis showed that BMI〔OR=1.985, 95%CI (1.616, 2.438) 〕, VAT〔OR=1.126, 95%CI (1.088, 1.165) 〕, TAT〔OR=1.028, 95%CI (1.019, 1.038) 〕 were associated with AP (P<0.05) . BMI〔OR=7.543, 95%CI (2.576, 22.088) 〕and TAT〔OR=1.074, 95%CI (1.038, 1.111) 〕were associated with the severity of AP (P<0.05) . For predicting AP, the AUC of BMI was 0.833〔95%CI (0.777, 0.888) , P<0.001〕, with 90.0% sensitivity and 62.0% specificity when the optimal cut-off value was chosen as 17.610 kg/m2; the AUC of VAT was 0.939〔95%CI (0.909, 0.969) , P<0.001〕, with 84.0% sensitivity and 89.0% specificity when the optimal cut-off value was chosen as 104.250 cm2; the AUC of TAT was 0.800〔95%CI (0.739, 0.860) , P<0.001〕, with 83.0% sensitivity and 66.0% specificity when the optimal cut-off value was chosen as 184.995 cm2. When it comes to predicting the severity of AP, the AUC of TAT was 0.910〔95%CI (0.844, 0.976) , P<0.001〕, with 84.0% sensitivity and 84.0% specificity when the optimal cut-off value was chosen as 201.357 cm2, and the AUC of BMI was 0.928〔95%CI (0.856, 1.000) , P<0.001〕, with 88.0% sensitivity and 89.3% specificity when the optimal cut-off value was chosen as 21.180 kg/m2.
CT-assessed abdominal fat content and distribution may be closely associated with AP and its severity. It is suggested to include CT quantitative measurement of abdominal fat content and distribution in the AP diagnosis, severity assessment and treatment system since the two indicators reflect relevant information that could be used as scientific evidence.
Hereditary pancreatitis (HP) is a rare autosomal genetic disease that is often manifested by recurrent pancreatitis and complicated type 3c diabetes mellitus (T3cDM) , and even leads to pancreatic cancer, impairing the quality of life and prognosis of patients. We reported a child with HP caused by p.Val39Ala (V39A) mutation of the PRSS1 gene with a pedigree analysis, which is the first case report in China, hoping to provide clinicians with evidence for the diagnosis and treatment of HP.
Previous studies have shown that the risk of acute pancreatitis (AP) is increased in obesity population, while obese patients are often combined with abnormal fasting plasma glucose (FPG). It still remians controversial whether FPG independently increases the risk of AP and the relationship between FPG and the risk of AP in non-obese patients has been rarely reported in China and abroad.
To explore the association between baseline FPG level and the risk of AP in non-obese population.
Using a prospective cohort study method, a total of 102 512 non-obese cases from the Kailuan study cohort who completed physical examination for the first time in KaiLuan General Hospital and its 10 affiliated hospitals from 2006 to 2009 were enrolled as study subjects. Epidemiological data, anthropometric data, laboratory test indicators and other information of the subjects were collected. The study subjects were divided into 4 groups according to the FPG quartile: the first quartile group (group Q1, FPG≤4.66 mmol/L, n=25 929) ; the second quartile group (group Q2, 4.66 mmol/L≤FPG<5.10 mmol/L, n=25 797) ; the third quartile group (group Q3, 5.10 mmol/L≤FPG<5.67 mmol/L, n=25 162) ; the fourth quartile group (group Q4, FPG≥5.67 mmol/L, n=25 624). The Kaplan-Meier method was used to plot the survival curves of new-onset AP in non-obese population. The cumulative incidence of AP in non-obese population in different FPG level groups were calculated and Log-rank method was used for inter-group test. The Cox proportional hazard regression model was used to analyze the influencing factors for the new-onset AP in non-obese population and the correlation between different FPG level groupings and new-onset AP in non-obese population.
The median follow-up time in this study was (12.8±2.4) years with the cumulative incidence of 320 cases and incidence density of 2.44 cases per 10 000 person-years in AP. There were statistically significant differences in the cumulative incidence of AP among the 4 FPG level groups (χ2=13.96, P<0.001). The results of Cox proportional hazard regression analysis showed that advanced age〔HR=1.02, 95%CI (1.01, 1.03), P=0.001〕, high triacylglycerol (TG) level〔HR=1.22, 95%CI (1.13, 1.30), P<0.001〕, history of cholithiasis〔HR=2.79, 95%CI (1.88, 4.13), P<0.001〕were risk factors for new-onset AP in non-obese population. Years of education ≥9 years〔HR=0.65, 95%CI (0.47, 0.90), P<0.001〕was the protective factor for new-onset AP in non-obese population. The HR for new-onset AP in group Q4 was 1.40 〔95%CI (1.02, 1.92), P=0.038〕. After excluding the population applying hypoglycemic drugs, the conclusions were unchanged, the HR for new-onset AP in group Q4 was 1.40 〔95%CI (1.02, 1.92), P=0.036〕.
Advanced age, high TG levels, and history of cholithiasis are risk factors for new-onset AP, years of education ≥9 years is the protective factor for new-onset AP. And the risk of AP increases when FPG ≥5.67 mmol/L in non-obose population.
【Abstract】Background Frailty-related issue is increasingly prominent with the acceleration of aging in China.However, domestic research on frailty is still in its infancy characterized by non-objective diagnosis basis, unclear pathogenesis and imperfect interventions.Objective To investigate the correlation of 25-hydroxyvitamin D and interleukin-6 with frailty in elderly patients with chronic disease in the stable phase,so asto explore objective diagnostic basis and new interventions for frailty. Methods A total of 152 inpatients (≥ 60 years old) with chronic disease in the stable phase were recruited from Department of Geriatrics,the First People's Hospital of Yunnan Province(hereinafter referred to as “the department of the hospital”) from November 2020 to April 2021. Clinic and laboratory data were collected. Comprehensive geriatric assessment was conducted via an internet-based platform of the Comprehensive Geriatric Assessment(inpatient version) developed by the department of the hospital,among which frailty was assessed by the Chinese version of Fried Frailty Phenotype,a component of the assessment scale. Results Among the 152 patients,47(30.9%) had no frailty,51(33.6%) had pre-frailty and 54(35.6%) had frailty. According to the binary Logistic regression analysis,disability〔OR=6.162,95%CI(1.091,34.789),P=0.039〕, 25-hydroxyvitamin D〔OR=0.901,95%CI(0.825,0.985),P=0.022〕 and interleukin-6〔OR=1.103,95%CI(1.012,1.201),P=0.025〕 were influencing factors for frailty in elderly patients with chronic disease in the stable phase. Conclusion Sufficient 25-hydroxyvitamin D may be associated with decreased risk of frailty and elevated interleukin-6 may be associated with increased risk of frailty in elderly patients with chronic disease in the stable phase. So these two indicators may be potential targets for predicting and treating frailty.
【Key words】 Frailty;Aged;Chronic disease;25-hydroxy-vitamin D;Vitamin D;Interleukin-6
【Chinese Library Classification Number】R 151.1 【Document Identification Code】A
1.Introduction
Frailty is a special state in which the physical functions of the elderly gradually decline. It is characterized by weakened muscle strength and endurance, decreased physiological functions, increased vulnerability, decreased anti-stress ability with subsequent adverse consequences such as falls, disability, cognitive impairment, mental abnormalities, and even death[1][2]. To identify high-risk older adults, Fried et al.[3]roposed the use of a clinical phenotype to characterize frailty, which consisted of five body components, including decreased muscle strength, reduced walking speed, fatigue, reduced physical activity and unconscious weight loss. These criteria are now widely used in clinical research for the diagnosis of frailty.
With the aging of the Chinese population, the problem of frailty in old age is increasingly serious. However, frailty specific diagnosis is not objective, the pathogenesis is not clear, and the intervention is not sound, indicating that the current research on this matter is yet in its infancy. Although there are previous studies that have explored the possibility of symptoms related to the geriatric syndrome, such as cognitive function, daily activity ability, anxiety and depression and others, to diagnose frailty more confidently and precisely, data on the correlation between 25- hydroxyvitamin D (25(OH)D), interleukin (IL)-6 and frailty in elderly are still missing. Therefore, we aim to explore the correlation between senile frailty and 25(OH)D and IL-6, so asto lay a foundation for the objective diagnosis and intervention of senile frailty in the future.
2 Objects and Methods
2.1 Research objects
152 patients at the age of 60 years and above, diagnosed with a chronic disease in the stable phase were recruited at the Department of Geriatrics, the First People's Hospital of Yunnan Province, China. The inclusion criteria were as follows: 1) previously hospitalized patients with no new disease, aged ≥ 60 years without new disease, 2) patients with no communication barriers and able to cooperate in the comprehensive geriatric assessment (CGA), and 3) patients who were voluntarily participating in the study and have signed the informed consent. The applied exclusion criteria were: 1) elderly people who have been supplemented with Vitamin D and anti-inflammatory drugs in the past one month, 2) patients, who were diagnosed with acute infectious diseases recently, 3) patients with serious physical and/or mental diseases with communication barriers, who were unable to complete the Fried scale assessment, 4) patients who were bedridden or unstable for a long time and 5) patientswho had insufficient information on the evaluation scale or laboratory data.
This study was implemented after approval of the Medical Ethics Committee of the First People's Hospital of Yunnan Province (No. KHLL2021-KY034).
2.2 Data Collection
2.2.1 General information
Patients’ general information, including age, gender, height, body mass, body mass index (BMI), educational level, allergyhistory, vision or hearing loss, presence or absence of dentures, marital status, eating habits, sleep time, sleep aids supplementation, current smoking (referring to smoking in the last 30 days before the survey), current drinking (referring to the alcohol consumption in the last 30 days before the survey) were collected.
2.2.2 Comprehensive Geriatric Assessment (CGA)
The internet-based platform of the Comprehensive Geriatric Assessment (inpatient version) is a software independently developed by the Department of Geriatrics, First People's Hospital of Yunnan Province, China and was applied in the current study. It consists of several national general assessment scales and has certain intelligence. The calculated scores and evaluation results were given automatically according to each assessment option following the criteria and reference scope formulated by various general scales. The researchers collected patients’ data through a WeChat mini-program or computer, and Excel forms were automatically generated for data summary later. The assessors were geriatricians who have received the "Comprehensive Geriatric Assessment System" software training. The assessment included mainly nutritional status assessment and the Micronutrient Assessment Scale (MNA-SF) was used. Values ≥ 24 were considered as indicators of good nutrition, betwen17 and 24 were designated as potential malnutrition, while between 0 and 17 were classified as malnutrition. The cognitive function assessment was according to the Simple Mental State Examination Scale (MMSE), where values between 0 and 9 were classified as a severe impairment, between 10 and 20 - as moderate impairment, between 21 and 26 were classified as mild impairment, while scores between 27 and 30 were designated as cognitive normal functions. Evaluation of anxiety and depression followed the Geriatric Depression Scale (GDS-15), where scores ≥ 6 indicated anxiety and depression. Evaluation of depression following the Self-rating Depression Scale (SDS) was used and the T scores <50 indicated no presence of depression, whereas T ≥ 50 was classified as a depressive mental state. The evaluation of anxiety was according to the Self-rating Anxiety Scale (SAS), where scores <50 indicated lack of anxiety, while equal and above 50 was categorized as anxiety. Daily living ability assessment was according to the basic Living activity ability (BADL) scale, where scores between 91 and 100 were indicators of good daily living function, between 61 and 90 were regarded as mild functional impairment, between 41 and 60 was labeled as moderate functional impairment, between 21 and 40 were considered as severe functional impairment, whereas patients with scores between 0 and 20 were grouped as completely disabled. Instrumental living ability assessment was according to the Instrumental Ability of Daily Living (IADL) scale was used to assess whether patients were able to go shopping, go out for activities, cook food, maintain household chores and wash clothes. Those who need assistance in 3 or more of these criteria were considered disabled. The sleep status assessment was done according to the Assens Insomnia Scale (AIS), where scores between 0 and 3 indicated good sleep, between 4 and 6 spoke for potential insomnia, whereas between 7 and 24 indicated insomnia. Fall risk assessment was according to the Morse Fall Risk Assessment Scale, where scores between 0 and 24 classified the patients at low risk of fall, between 25 and 44 categorized the patients at moderate risk, whereas scores equal and above ≥ 45 categorized the elderly people at severe risk. The balance function evaluation was agreeing with the Tinetti balance and gait scale, where scores less than 15 indicated the risk of falling, between 15 and 24 designated balance dysfunction, whereas scores ≥ 24 indicated good physical function. The visual simulation method was used for pain evaluation. Scores equal to 0 indicated lack of pain, between 1 and 3 designated mild pain, between 4 and 6 showed the presence of moderate pain, whereas between 7 and 10 indicated presence of severe pain. The evaluation of urinary incontinence was in harmony with the Incontinence Questionnaire Simple Form (ICI-Q-SF), where scores equal to 0 classified the patients into the group of asymptomaticurinary incontinence, between 1 and 7 determined the elderly people with mildurinary incontinence, between 8 and 14 indicated moderateurinary incontinence, whereas the scores between 15 and 21 indicated that the patients had severe urinary incontinence. Constipation was assessed using the Roma = 3 \* ROMAN III Scale (≥2). Other parameters that were taken into account included falls (within the last 1 year), the number of chronic diseases, the coexistence of multiple diseases (≥ 2 diseases), multiple medications (≥ 5 oral medications), the number of medications and others. All these allowed to assess and diagnose frailty and evaluating scores are presented in Table 1.
Table 1 Contents of the Chinese version of Fried method for evaluation and classification of frailty among elderly people
variable
Overall
(n=288)
Non-Frailty(n=87)
Pre-Frailty(n=93)
Frailty(n=108)
χ2(F) value
P value
age a(years)
67.501
<0.001**
<75 years old
111(38.5)
50(67.8)
37(39.8)
15(13.9)
≥75,<85 years old
92(31.9)
24(27.6)
35(37.6)
33(30.6)
≥85 years old
82(29.5)
4(4.6)
21(22.6)
60(55.6)
gender b
1.527
0.466
male
173(60.1)
48(55.2)
56(60.2)
69(63.9)
Female
115(39.9)
39(44.8)
39(36.1)
BMI a,mean ± SD
23.28±4.14
23.63±3.41
23.42±5.54
22.87±3.15
0.897
0.409
Education level b
7.599
0.269
illiteracy
12(4.2)
1(1.1)
6(6.5)
5(4.6)
primary school
155(53.8)
51(58.6)
44(47.3)
Middle school
66(29.9)
15(17.2)
26(28.0)
25(23.1)
College degree and above
55(19.1)
20(23.0)
17(18.3)
18(16.7)
Vision condition b
9.617
0.008*
normal
87(30.2)
39(41.9)
24(22.2)
decline
201(69.8)
63(72.4)
54(58.1)
84(77.8)
Hearing condition b
20.417
41(44.1)
26(24.1)
52(55.9)
82(75.9)
marital status b
4.667
0.097
Married
222(77.1)
72(82.8)
74(79.6)
76(70.4)
Divorced/Widowed
66(22.9)
19(20.4)
32(29.6)
Eating habits b
2.114
0.347
Light diet mainly
248(86.1)
71(81.6)
82(88.2)
95(88.0)
Mainly salty and greasy diet
40(13.9)
16(18.4)
11(11.8)
13(12.0)
sleeping time(h) a ,mean ± SD
6.74±1.69
7.08±1.78
7.19±2.09
1.459
0.234
Smoking status b
1.363
0.506
Not currently smoking
224(77.8)
65(74.7)
76(81.7)
83(76.9)
Current smoking
64(22.2)
22(25.3)
Drinking situation b
3.529
0.171
Not currently drinking
242(84.0)
68(78.2)
92(85.2)
Current drinking
46(16.0)
19(21.8)
16(14.8)
Number of chronic diseases (species) a,mean ± SD
7.72±3.39
6.70±3.59
7.46±3.45
8.75±4.23
7.297
0.001*
Polypharmacy(kind) b
14.734
No Polypharmacy
103(35.8)
44(50.6)
33(35.5)
There are Polypharmacy (≥5 species)
185(64.2)
43(49.4)
60(64.5)
Note: The lack of compliance with any of the items listed in Table 1 indicated a lack of frailty. The compliance with 1 and/or 2 items indicated a pre-frailty condition, while the compliance with 3 items was firmly diagnosed as frailty; IPAQ = International Physical Activity Scale
2.2.3 Laboratory examination
30 ml of fasting venous blood was collected from the hospitalized elderly patients from 6:00 to 8:00 am and sent to the clinical laboratory of our hospital for testing. The automatic analyzer Xiang Instrument L1550 was used for blood samples analyse. The blood was centrifuged at 3 500 r/min for 5 min. The detected parameters included the white blood cells (WBC) and red blood cells count (RBC), haemoglobin (Hb), platelets (PLT) and neutrophils count (NEUT), as well as the C-reactive protein (CRP). The aspartate (AST) and alanine aminotransferase (ALT) were detected by the rate method. Triacylglycerols (TG) were detected by the deionization glycerol method, the total protein (TP) was detected by the biuret method, albumin (ALB) was detected by the bromocresol green method, while the total cholesterol (TC) was detected by the cholesterol oxidase method. High density (HDL) and low-density lipoproteins (LDL) were detected by the elimination method. Blood sodium (Na+), blood potassium (K+) and blood chlorine (Cl-) were detected by the ion-selective electrode method. Creatinine (Cr) and glycosylated haemoglobin (HbA1c) were assayed by enzyme reactions. Urea nitrogen (BUN) was assayed by the urease UV rate method. Uric acid (UA) was assayed by enzyme calorimetry. Blood calcium (Ca2+) was assessed by the arsenazo ⅲ method. The Hexokinase method was used for assessing the amount of fasting blood glucose. Fructosamine was detected by the tetrazolium blue method. Thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroid hormone (T4), free triiodothyronine (FT3), free thyroid hormone (FT4), ferritin, vitamin B12, folic acid, 25(OH)D, estradiol, testosterone, homocysteine (Hcy), fasting insulin (FINS) were detected by electrochemiluminescence. Activated partial thrombin time (APTT), prothrombin time (PT), thrombin time (TT) and D-dimer (DD2) were detected by the magnetic bead method or by immunoturbidimetry. Tumour necrosis factor (TNF), IL-10, IL-6, IL-12P70, IL-1 and IL-8 were detected by chemiluminescence.
2.2.4 Data quality control
To assure the gathered data quality all assessment physicians passed the training programme for assessment of the Comprehensive Geriatric Assessment System Software Platform (Inpatient version). All incomplete or inconsistent data were regarded as invalid data and thus excluded from the study.
2.3 Statistical Methods
SPSS 23.0 software was used for statistical analysis. The measurement data (
3 Results
152 elderly patients were included in the study, among them, 47 (30.9%) had no frailty, 51 (33.6%) had early frailty and 54 (35.6%) had frailty.
3.1 Comparison of general data and geriatric syndrome of patients with different degrees of frailty
There were no significant differences in gender, height, body mass, BMI, education level, food or drug allergy, denture, marital status, eating habits, sleep time, use of sleeping supplementation, current smoking and alcohol consumption, present anxiety, fall, pain, urinary incontinence, constipation and multiple diseases among patients with different degrees of frailty (P > 0.05). There were statistically significant differences in age, visual impairment, hearing impairment, nutritional status, cognitive function, presence of anxiety and depression, presence of anxiety, daily living ability, disability, sleep status, fall risk, balance function, number of chronic diseases, multiple medications, number of medications(P <0.05). These data are shown in Table 2.
Table 2 Comparison of clinical data and geriatric syndromes in participants by level of frailty
frailty degree
no frailty (n=47)
pre-frailty(n=51)
frailty (n=54)
Age (±s, years)
74.45±8.035
80.29±8.81
85.17±7.06
22.678a
<0.001
Gender〔n(%)〕
1.263
0.532
25(53.2)
32(62.7)
34(63.0)
female
22(46.8)
19(37.3)
20(37.0)
height(±s,m)
1.60±0.88
1.61±0.06
1.62±0.08
0.815a
0.444
Body mass(±s,kg)
59.57±11.15
58.52±10.63
60.60±10.30
0.494
0.611
BMI( ±s,kg/m2)
24.47±2.69
24.17±1.90
23.84±2.21
0.959a
0.385
Education level〔n(%)〕
13.692
0.090
0(0.0)
2(3.9)
4(7.4)
17(36.2)
13(25.5)
18(33.3)
junior high school
20(42.6)
13(24.1)
high school
5(10.6)
15(29.4)
9(16.7)
8(15.7)
10(18.5)
Food or medicineHistory of allergies〔N(%)〕
11(23.4)
0.776
0.678
Vision loss〔N(%)〕
30(63.8)
31(60.8)
44(81.5)
6.138
0.046
Hearing loss〔N(%)〕
9.790
0.007
Have false teeth〔n(%)〕
25(49.0)
33(61.1)
1.602
0.449
8(17.0)
16(29.6)
2.224
0.329
Eating habits〔n(%)〕
0.035
0.983
Light diet
40(85.1)
44(86.3)
46(85.2)
Greasy diet
7(14.9)
7(13.7)
8(14.8)
sleeping time(±s,h/d)
6.55±1.84
7.18±2.17
7.22±1.81
1.794a
0.170
TakeSleeping aids〔N(%)〕
9(17.6)
11(20.4)
0.218
Current smoking〔N(%)〕
13(27.7)
12(23.5)
17(31.5)
0.829
0.661
Current drinking〔 N (%)
9(19.1)
10(19.6)
0.024
0.988
Nutritional status〔n(%)〕
30.644
Good nutrition
29(61.7)
23(45.1)
Potential malnutrition
16(34.0)
26(51.0)
23(42.6)
Severe malnutrition
2(4.3)
Cognitive function〔n(%)〕
51.111
Good cognitive function
33(70.2)
21(41.2)
13(8.6)
Mild cognitive impairment
24(47.1)
Moderate cognitive impairment
1(2.1)
6(11.8)
Severe cognitive impairment
0.(0.0)
Anxiety and depression
〔N(%)〕
19(40.4)
35(68.6)
43(79.6)
17.495
Existence suppression
Depression〔N(%)〕
18(38.3)
36(70.6)
42(77.8)
18.654
ExistenceWorry state〔N(%)〕
3(5.9)
5(9.3)
1.084
0.581
Ability of daily living [n (%)]
87.800
Good daily function
3(5.5)
Mild dysfunction
22(43.1)
19(35.2)
Moderate dysfunction
7(13.0)
Severe dysfunction
25(46.3)
Disability〔N(%)〕
48(90.6)
51.821
Sleep condition〔n(%)〕
12.017
0.017
Sleep well
18(35.3)
Potential insomnia
11(21.6)
14(25.9)
Insomnia
24(44.4)
Nearly 1 yearFall〔n(%)〕
1.616
0.446
Risk of falling [n(%)]
9.603
0.048
Low risk
39(83.0)
37(72.5)
31(57.4)
Moderate risk
6(12.8)
Severe risk
12(22.2)
Balance function〔n(%)〕
16.314
0.003
Function well
28(59.6)
15(27.8)
Balance disorder
Risk of falling
21(38.9)
Have pain〔N(%)〕
26(56.5)
29(56.9)
32(59.3)
0.094
0.954
Urinary incontinence〔N(%)〕
3(6.4)
3.614
0.164
constipate〔N(%)〕
14(27.5)
0.503
0.778
Number of chronic diseases
(±s, kind)
4.87±2.29
5.86±2.12
6.39±2.80
4.985a
0.008
Multiple diseases coexist
45(95.7)
51(100.0)
52(96.3)
2.104
0.349
Multi-drug〔N(%)〕
24(51.1)
38(74.5)
36(66.7)
6.046
0.049
Number of medications(±s, kind)
5.15±2.53
6.22±2.82
6.81±3.35
3.987
0.021
Note: Pain = mild pain + moderate pain + severe pain; urinary incontinence = mild urinary incontinence + moderate urinary incontinence + severe urinary incontinence; a represents F value; BMI = body mass index
3.2 Comparison of the laboratory examination indexes of the elderly patients with different degrees of frailty
There were no significant differences in the WBC, RBC, PLT, NEUT, CRP, AST, TG, TP, TC, HDL, LDL, K+, Cr, HbA1c, BUN, UA, Ca2+, fasting blood glucose, glucosamine, TSH, T3, T4, FT3, FT4, ferritin, vitamin B12, folic acid, testosterone, FINS, TT, TNF, IL-10, IL-12P70, IL-1 among the studied patients with different degrees of frailty (P>0.05). Statistically significant differences were found in the Hb, ALT, ALB, Na+, Cl-, (25(OH)D, estradiol, Hcy,, APTT, PT, DD2, IL-6 and IL-8 (P<0.05). These parameters and interactions are shown in Table 3.
Table 3 Comparison of the laboratory indicators in the elderly participants by the level of frailty
Z( F ) value
WBC 〔M(P25,P75),
×109 /L〕
6.82(5.26,7.76)
6.16(4.89,7.22)
5.93(5.07,7.26)
1.520
0.285
RBC〔M(P25,P75),
×1012/L〕
4.34(3.99,4.64)
4.39(4.07,4.71)
4.10(3.44,4.59)
8.158
0.077
Hb(g/L)
132.43±24.84
137.43±17.65
121.44±27.33
6.276
0.002
PLT〔M(P25,P75),
210.00(168.00,248.00)
194.00(151.00,235.00)
180.50(137.00,224.25)
4.028
NEUT〔M(P25,P75),
4.54(2.74,5.35)
3.81(2.95,4.71)
4.09(2.95,4.96)
1.487
0.084
CRP〔M(P25,P75), mg/L〕
2.35(0.50,20.75)
3.04(1.31,11.42)
11.17(2.67,28.05)
8.650
0.056
AST〔M(P25,P75), U/L〕
20.00(15.00,27.00)
19.00(15.00,24.00)
18.50(15.00,26.00)
0.419
0.770
ALT 〔M(P25,P75),U/L〕
14.00(10.00,25.00)
16.00(10.00,20.00)
12.00(8.00,19.00)
4.242
0.030
TG 〔M(P25,P75),mmol/L〕
1.18(0.85,1.84)
1.25(0.85,1.96)
1.10(0.74,1.61)
2.263
0.439
TP(g/L)
64.28±7.07
63.48±6.60
63.72±9.38
0.133
0.875
ALB(g/L)
37.20±4.96
36.50±4.14
34.18±3.52
7.250
0.001
TC(mmol/L)
4.16±1.25
4.11±1.00
3.87±1.05
1.040
0.356
HDL(mmol/L)
1.08±0.37
1.05±0.28
1.00±0.28
0.803
0.450
LDL(mmol/L)
2.51±1.00
2.43±0.79
2.28±0.87
0.936
0.395
Na+(mmol/L)
139.34±2.96
139.51±2.87
137.33±4.02
6.844
K+(mmol/L)
3.96±0.47
4.00±0.45
3.97±0.49
0.034
0.966
Cl-〔M(P25,P75),
mmol/L〕
108.00(106.00,110.00)
107.00(105.00,110.00)
106.00(102.75,108.00)
9.637
Cr〔M(P25,P75),μmol/L〕
72.00(60.00,90.00)
77.00(63.00,95.00)
83.00(67.50,114.00)
5.176
0.147
HbA1c〔M(P25,P75),%〕
6.25(5.82,7.75)
6.31(5.81,7.74)
6.02(5.57,6.82)
4.246
0.160
BUN〔M(P25,P75),μmol/L〕
6.40(4.90,8.70)
6.80(4.90,8.90)
7.85(5.68,10.10)
3.946
0.225
UA〔M(P25,P75)μmol/L〕
362.00(285.00,425.00)
396.00(339.00,457.00)
346.00(261.25,504.75)
4.083
0.069
Ca2+〔M(P25,P75),mmol/L〕
2.19(2.09,2.28)
2.19(2.10,2.26)
2.18(2.10,2.24)
0.486
Fasting blood glucose〔M(P25,P75), mmol/L]
5.40(4.60,6.80)
4.90(4.40,6.60)
4.85(4.20,6.00)
3.010
0.140
Fructosamin〔M(P25,P75),μmol/L]
1.60(1.46,1.76)
1.55(1.44,1.66)
1.54(1.37,1.70)
1.231
0.786
TSH〔M(P25,P75),mU/L〕
2.83(1.49,4.38)
2.73(1.50,4.51)
2.28(1.30,4.51)
0.231
0.544
T3〔M(P25,P75),nmol/L〕
1.04(0.81,1.30)
0.95(0.80,1.28)
0.96(0.72,1.16)
2.450
0.277
T4〔M(P25,P75)nmol/L〕
76.33(66.67,80.07)
76.33(65.58,90.15)
72.55(64.11,83.71)
0.809
0.781
FT3〔M(P25,P75),pmol/L〕
4.37(3.92,4.97)
4.29(3.41,4.77)
4.17(3.16,4.70)
3.854
FT4〔M(P25,P75),pmol/L〕
12.41(10.88,14.53)
12.25(9.92,14.72)
13.23(11.67,15.14)
2.435
0.238
APTT(s)
36.01±4.19
37.51±4.44
39.29±5.53
5.943
PT〔M(P25,P75),s〕
12.80(12.20,13.40)
12.90(12.40,13.50)
13.30(12.78,14.18)
12.309
0.010
TT〔M(P25,P75),s〕
18.10(17.20,18.80)
18.30(17.60,19.20)
18.00(17.18,18.70)
2.184
0.668
DD2(ug/ml)
1.18(0.90,2.11)
1.33(1.00,2.06)
2.00(1.29,4.39)
16.137
0.009
Ferritin〔M(P25,P75), ng/ml〕
237.07(181.59,418.50)
225.96(95.43,378,26)
224.03(106.48,480.20)
1.025
0.676
Vitamin B12〔M(P25,P75), pmol/L〕
297.00(225.00,498.77)
344.00(224.00,462.00)
394.50(260.25,924.50)
5.727
0.654
Folic acid 〔M(P25,P75),nmol/L〕
15.50(9.80,22.80)
15.50(9.60,24.80)
12.70(7.68,28.25)
0.733
0.325
25(OH)D(μg/L)
22.72±9.69
19.60±9.42
17.14±6.59
5.282
0.006
Estradiol (Pmol/L)
111.61±53.60
125.17±62.47
149.60±52.97
5.919
Testosterone (nmol/L)
1.86(0.51,13.24)
2.84(0.54,15.20)
4.77(0.57,13.51)
0.162
Hcy〔M(P25,P75),μmol/L〕
14.40(11.90,17.95)
16.80(14.20,19.10)
17.95(15.00,23.63)
7.705
0.015
FINS〔M(P25, P75),U/L〕
6.92(4.94,11.52)
6.06(3.90,9.04)
6.77(4.16,8.62)
2.150
0.600
TNF〔M(P25,P75),ng/L〕
5.98(4.18,12.87)
6.32(4.18,13.20)
6.15(5.20,10.39)
0.597
0.832
IL-10〔M(P25,P75),ng/L〕
4.33(3.48,5.38)
4.75(3.70,6.30)
4.92(3.68,6.46)
3.196
IL-6〔M(P25,P75),ng/L〕
12.61(5.95,18.37)
20.88(7.82,34.01)
25.29(17.21,46.79)
31.520
IL-12P70〔M(P25, P75),ng/L〕
5.22(3.57,5.92)
4.99(2.04,5.80)
5.56(4.64,6.32)
4.078
0.165
IL-1ß〔M(P25,P75),ng/L〕
4.65(3.64,7.59)
4.93(3.45,8.02)
4.65(3.91,7.22)
0.408
0.873
IL-8〔M(P25,P75),ng/L〕
19.46(12.77,38.93)
41.67(18.53,90.28)
25.65(14.64,60.40)
8.685
Note: WBC=white blood cell count, RBC=red blood cell count, Hb=hemoglobin, PLT=platelet count, NEUT=neutrophil fraction, CRP=C reactive protein, AST=aspartate aminotransferase, ALT=alanine aminotransferase, TG=triacylglycerol, TP=total protein, ALB=albumin, TC=total cholesterol, HDL=high-density lipoprotein, LDL=low-density lipoprotein, Na+=serum sodium, K+=serum potassium, Cl-= blood chlorine, Cr= creatinine, HbA1c= glycosylated hemoglobin, BUN= urea nitrogen, UA= uric acid, Ca2+=blood calcium, TSH= thyroid stimulating hormone, T3= triiodothyronine, T4= thyroid hormone, FT3= Free triiodothyronine, FT4 = free thyroid hormone, 25 (OH) D = 25 hydroxyvitamin D, Hcy = homocysteine, FINS = fasting insulin, APTT = activated partial thromboplastin time, PT = coagulation proenzyme time, TT = thrombin time, DD2 = D-dimer, TNF = tumor necrosis factor, IL = interleukin; a represents F value
3.3 Binary Logistic regression analysis
Taking frailty of elderly patients with stable chronic diseases as a dependent variable, where 1 indicated lack of frailty and 2 designated pre-frailty and frailty, all variables with statistically significant differences (P<0.05) demonstrated in Tables 1 and 2 were taken as independent variables. These included the age (assigned: measured value), vision (where 0 was normal and 1 was decreased), hearing (where 0 was normal and 1 was accepted as decreased), nutritional status (where 0 indicated good nutrition, 1 - potential malnutrition and 2 - malnutrition), cognitive function (where 0 was normal cognition and 1 was cognitive impairment), anxiety and depression states (where 0 was accepted as no anxiety and depression state, whereas 1 was classified with anxiety and depression state, depression state (where 0 indicated no depression state, whereas 1 indicated presence of such), daily living ability (where 0 was indicative of good daily life function, while 1signified dysfunction of daily life), disability (where 0 indicated not disabled and 1 - complete disability), sleep status (with 0 equal to good sleep, 1equal to potential insomnia, whereas 2 represented insomnia), risk of fall (where 0 indicated low risk, 1- moderate risk, while 2 indicated severe risk), balance function (where 0 stood for good physical function, 1 for balance dysfunction, whereas 2 indicated risk of fall), number of chronic diseases (measured value), multiple medications (where 0 indicated none and 1 indicated presence), number of medications (measured value), Hb (measured value), ALT (measured value), ALB (measured value), Na+ (measured value), Cl- (measured value), 25- (OH) D (measured value), estradiol (measured value), Hcy (measured value), APTT (measured value), PT (measured value), DD2 (measured value), IL-6 (measured value), IL-8 (measured value). Binary Logistic regression analysis showed that the disability, 25-(OH)D and IL-6 were the independent influencing factors in elderly patients with stable chronic diseases (P<0.05), as shown in Table 4.
Table 4 Binary logistic regression analysis of frailty in elderly patients with chronic disease
β
SE
Wald x2 value
OR(95%CI)
Disability
1.818
0.883
4.240
0.039
6.162(1.091,34.789)
25-(OH)D
-0.104
0.045
5.238
0.022
0.901(0.825,0.985)
IL-6
0.098
0.044
5.008
0.025
1.103(1.012,1.201)
4 Discussion
4.1 Occurrence of senile frailty and independent related factors
Our results showed that the overall incidence of frailty in the studied hospitalized elderly patients was 35.6% (54/152), which was similar to the results of Lai Xiaoxing et al.[4], Wei Yin et al.[5]and others[6], where the estimated incidence rate was 31.3%, 34.4% and 35.4%, respectively, which was higher than that estimated one by Wang Wanwan et al.[7], whose calculations showed an incidence of the frailty of 25.1%. Interestingly, these estimations were lower than that by Jin Qiulu et al.[8], who found that the frailty rate of elderly patients (≥ 80 years old) was 41.6%. These differences in the prevalence and incidence rate of frailty among elderly people may be due to different assessment tools, age, and study subjects.However,overall, the prevalence of frailty in China is not optimistic.Considering that is often followed by a variety of adverse consequences[1-2], early screening, prevention and intervention can greatly reduce the prevalence and hospitalization rate of elderly people with frailty.
Other authors’ studies in the United States, Mexico, Australia and other countries have shown that Vitamin D (25(OH)D) is an independent factor affecting frailty[9][11]. In addition, another analysis involving that 20 355 subjects from 13 studies demonstrated a significant inverse relationship between the 25(OH)D levels in patients’ blood results and increased frailty severity (following Fried's phenotypic definition) in both the original analysis and sensitivity analysis[12]. The results of our study are consistent with those of the above. However, according to a cross-sectional study of community women aged ≥ 75 years in Belgium, there no relationship between low vitamin D levels and lower limb muscle strength and grip strength was estimated[13]. The reason for this variance may be that the study from Belgium only targeted community women ≥ 75 years. Moreover, the levels of 25(OH)D in the blood are influenced by multiple factors, such as gender, age, geography and others, therefore these results may be somewhat limited.
According to multiple other meta-analyses, frailty and early frailty were associated with higher levels of CRP and IL-6[14][15]. This was confirmed by a recent meta-analysis of 23 910 older adults, where the authors proved that frailty and pre-frailty were associated with higher levels of inflammatory factors, especially CRP and IL-6[16]. Our research results were similar to the above studies. Although CRP was not an independent risk factor for frailty in our study, the single factor comparison was still statistically significant (P<0.05). The reason for this difference may be that the sample size of this study, which we understand that is relatively small. Second, the subjects were elderly patients with stable chronic diseases, and CRP was an acute phase reactant[17], therefore it was possible to rise under a variety of pathophysiological conditions. Therefore, this non-specific inflammatory marker was not considered as necessarily related to frailty[18].
4.2 25(OH)D, IL-6 and senile frailty are interrelated in elderly patients
25(OH)D is the major circulating metabolite of Vitamin D which is a globally recognized marker reflecting the Vitamin D status. Vitamin D deficiency is often associated with muscle weakness[19]. Vitamin D receptors (VDRs) are distributed in multiple target organs such as skin and muscles[20].VDRs act as nuclear receptor-mediated gene effects. VDRs bind to (1,25-(OH)2D) to induce the proliferation and differentiation of muscle fiber, and also affect the synthesis of related proteins. On the other hand, VDRs can also activate signal transduction pathways that can induce MAP kinase and phospholipase C through non-nuclear receptor-mediated non-genetic effects, so that a large number of calcium ions can rapidly flow into cells and affect muscle contraction[21][22]. Therefore, the possible mechanisms of 25(OH)D deficiency leading to frailty are due to affected muscle strength, resulting in decreased grip strength [23][24] and because of reduced development of muscle cells, ultimately leading to unconscious weight loss[25]. In addition, Vitamin D deficiency can also cause osteolysis secondary to hyperparathyroidism, leading to osteoporosis and even fracture, which can aggravate the progression of frailty and osteoporosis, leading to disability and other adverse events.
IL-6 levels increase with age[14], and high IL-6 can be used as a predictor of both the occurrence of sarcopenia and the adverse outcomes of frailty and sarcopenia, such as disability, functional decline and even death[26]. IL-6 can inhibit TNF-α and IL-1β and induce the production of CRP, fibrinogen and other acute-phase reactants[14], it can also indirectly reduce growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels, reduce protein synthesis and lead to sarcopenia. In addition, increased serum IL-6 and CRP levels were also associated with decreased grip strength[27]. The study of Maet al.[28]included 130 elderly patients and showed that IL-6 was negatively correlated with the strength and gait speed of the frailty elderly. IL-6 levels were also inversely associated with exercise tolerance in older adults after adjustment for age and gender. Therefore, we suggested that IL-6 could be applied as a biomarker for functional decline and frailty.
All the above studies suggest that high IL-6 levels are associated with senile frailty, and Vitamin D deficiency may be involved in inflammation and immune system activation[29]. Moreover, data are suggesting that Vitamin D supplementation reduced the levels of IL-6 in peripheral blood, inhibiting the production of IL-6 by peripheral blood monocytes, macrophages and T cells[30][31], and thus upregulating the expression of anti-inflammatory factors (such as IL-10) and inflammatory suppressor molecules[32].
4.3 Vitamin D supplementation as an intervention for reducing senile frailty
Some relevant epidemiological studies suggested that Vitamin D had a potential role in maintaining and improving muscle strength, function and physical performance, thus maintaining the independence of elderly people[33]. Other authors’ results demonstrated that the combined supplementation of elderly people with calcium and Vitamin D reduced the incidence of fractures and the risk of falls among them[34][36]. In addition, a randomized controlled trial of 5,615 participants showed only a slight improvement in the overall muscle strength after baseline Vitamin D supplementation[37]. Some data show that Vitamin D supplementation in elderly people may take longer or larger doses are needed before its beneficial effect on the muscles is present[38], to slow the progression of frailty[39]. Nonetheless, Cummingset al.[40]confirmed that the high-dose Vitamin D supplementation increased the risk of falls. Therefore, the ideal supplementation threshold for Vitamin D is a major question that needs special attention. According to the American Institute of Medicine, concentrations of 25(OH)D above 50 nmol/L are fully sufficient for human needs [41], while the American Endocrine Society sets the sufficient threshold above 72.5 nmol/L, the insufficiency threshold between 52.5 and 72.5 nmol/L, while the deficiency threshold is set at daily uptake concentrations less than 50 nmol/L[42]. Thus it can be seen that the dose critical value of vitamin D supplementation in the intervention of senile frailty needs further investigation.
5 Conclusion
The detected prevalence of senile frailty in hospitalized patients is not optimistic at all and is a burden to the medical and social systems in China. Therefore, the early screening, diagnosis and intervention of frailty are particularly essential. In this study, 25(OH)D and IL-6 were found to be independently correlated with frailty in elderly patients with stable chronic diseases. This indicates that 25(OH)D played as a protective factor of frailty in elderly patients with stable chronic diseases, while IL-6 was a risk factor. Therefore, 25(OH)D and IL-6 are expected to be predictors or objective biological indicators for the diagnosis of frailty in elderly patients with stable chronic diseases. In addition, Vitamin D supplementation may help prevent or delay senile frailty, though its dosage needs to be further discussed.
The innovativeness of this study can be summarized as follows:
1. The mobile software platform was successfully used to replace the traditional paper version for the evaluation of the senile frailty and related symptoms, which greatly reduced data collection time and statistical errors, thus increasing the reliability of the data.
2. The study of the senile frailty from the direction of the objective biomarkers in haematology and the mechanism of their action was described, which covered the lack of domestic research in this area.
3. This study proposed that 25-hydroxyvitamin D and interleukin-6 may be predictive or diagnostic factors of frailty in elderly patients with stable chronic diseases. Moreover, the hypothesis that Vitamin D supplementation of elderly patients may be a potential target for interventions is raised.
Like any other study, ours has some limitations too. The study was cross-sectional with a small sample size, which could not directly explore the causal relationship between the 25-hydroxyvitamin D, interleukin-6 and frailty. Second. it was a single-centre study with certain regional limitations. Finally, the subjects of this study were hospitalized elderly patients with stable chronic diseases, which could not represent the whole elderly population.
Author contribution: Dai Jingrong was responsible for the conception and design of the paper, the analysis and interpretation of the results, as well as the writing of the paper; Li Yan carried out the implementation and feasibility analysis of the research and was responsible for the quality control and review of the paper. Data collection was done by Li Jie, He Xu and Li Yang; He Xu and Li Yang, whosorted out and input data; Li Jie conducted the statistical processing and revised the paper; Dai Jingrong and Li Yan were responsible for the supervision and management of the article.
No conflict of interest is declared.
References
[1] APÓSTOLO J,COOKE R,BOBROWICZ-CAMPOS E,et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults:a systematic review[J]. JBI Database System Rev Implement Rep,2018,16(1):140-232. DOI:10.11124/JBISRIR-2017-003382.
[2] HOOGENDIJK E O,AFILALO J,ENSRUD K E,et al. Frailty:implications for clinical practice and public health[J].Lancet,2019,394(10206):1365-1375. DOI:10.1016/S0140-6736(19)31786-6.
[3] FRIED L P,TANGEN C M,WALSTON J,et al. Frailty in older adults:evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci,2001,56(3):M146-156. DOI:10.1093/gerona/56.3.m146.
[4] LAI X X,BO L,ZHU H W,et al. Relationship between sleep disorders and frailty in elderly inpatients[J]. Pract Geriatr, 2021,35(1):24-27.
[5] WEI Y,CAO Y P,YANG X L,et al. Frailty syndrome in hospitalized geriatric patients and its risk factors[J]. Fudan Univ J Med Sci,2018,45(4):496-502.
[6] VU H T T,NGUYEN T X,NGUYEN T N,et al. Prevalence of frailty and its associated factors in older hospitalised patients in Vietnam[J]. BMC Geriatr,2017,17(1):216. DOI: 10.1186/s12877-017-0609-y.
[7] WANG W W,LI Y Y,SHI X T,et al. Frailty-related factors and degree of association of frailty with malnutrition in elderly inpatients[J]. Chinese General Practice,2021,24(6):678- 684. DOI:10.12114/j.issn.1007-9572.2020.00.594
[8] JIN Q L,HU S,CHEN R,et al. Comprehensive geriatric assessment for screening risk factors and frailty in elderly inpatients[J]. Chinese General Practice,2018,21(27): 3296-3301. DOI:10.12114/j.issn.1007-9572.2018.00.150.
[9] KOJIMA G,TANABE M.Frailty is highly prevalent and associated with vitamin D deficiency in male nursing home residents[J]. J Am Geriatr Soc,2016,64(9):e33-35. DOI:10.1111/jgs.14268.
[10] WONG Y Y,MCCAUL K A,YEAP B B,et al. Low vitamin D status is an independent predictor of increased frailty and allcause mortality in older men:the Health in Men Study[J]. J Clin Endocrinol Metab,2013,98(9):3821-3828. DOI:10.1210/ jc.2013-1702.
[11] GUTIÉRREZ-ROBLEDO L M,ÁVILA-FUNES J A,AMIEVA H,et al. Association of low serum 25-hydroxyvitamin D levels with the frailty syndrome in Mexican community-dwelling elderly[J]. Aging Male,2016,19(1):58-63. DOI: 10.3109/13685538.2015.1105796.
[12] SMIT E,CRESPO C J,MICHAEL Y,et al. The effect of vitamin D and frailty on mortality among non-institutionalized US older adults[J]. Eur J Clin Nutr,2012,66(9):1024-1028. DOI:10.1038/ejcn.2012.67.
[13] MATHEÏ C,VAN POTTELBERGH G,VAES B,et al. No relation between vitamin D status and physical performance in the oldest old:results from the Belfrail study[J]. Age Ageing, 2013,42(2):186-190. DOI:10.1093/ageing/afs186.
[14] SOYSAL P,STUBBS B,LUCATO P,et al. Inflammation and frailty in the elderly:a systematic review and metaanalysis[J]. Ageing Res Rev,2016,31:1-8. DOI:10.1016/j. arr.2016.08.006.
[15] MARCOS-PÉREZ D,SÁNCHEZ-FLORES M,PROIETTI S,et al. Association of inflammatory mediators with frailty status in older adults:results from a systematic review and meta-analysis[J]. Geroscience,2020,42(6):1451-1473. DOI:10.1007/ s11357-020-00247-4.
[16] SOYSAL P,ARIK F,SMITH L,et al. Inflammation,frailty and cardiovascular disease[J]. Adv Exp Med Biol,2020,1216: 55-64. DOI:10.1007/978-3-030-33330-0_7.
[17] KANE A E,SINCLAIR D A.Frailty biomarkers in humans and rodents:Current approaches and future advances[J].Mech Ageing Dev,2019,180:117-128. DOI:10.1016/j. mad.2019.03.007.
[18] BAYLIS D,BARTLETT D B,SYDDALL H E,et al. Immuneendocrine biomarkers as predictors of frailty and mortality:a 10- year longitudinal study in community-dwelling older people[J]. Age (Dordr),2013,35(3):963-971. DOI:10.1007/ s11357-012-9396-8.
[19] WIMALAWANSA S J,RAZZAQUE M S,AL-DAGHRI N M.Calcium and vitamin D in human health:hype or real?[J]. J Steroid Biochem Mol Biol,2018,180:4-14. DOI:10.1016/j. jsbmb.2017.12.009.
[20] ABRAMS G D,FELDMAN D,SAFRAN M R.Effects of vitamin D on skeletal muscle and athletic performance[J]. J Am Acad Orthop Surg,2018,26(8):278-285. DOI: 10.5435/JAAOS-D-16-00464.
[21] CEGLIA L,HARRIS S S.Vitamin D and its role in skeletal muscle[J]. Calcif Tissue Int,2013,92(2):151-162. DOI: 10.1007/s00223-012-9645-y.
[22] HAMILTON B.Vitamin D and human skeletal muscle[J]. Scand J Med Sci Sports,2010,20(2):182-190. DOI:10.1111/ j.1600-0838.2009.01016.x.
[23] VITALE C,JANKOWSKA E,HILL L,et al. Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure[J]. Eur J Heart Fail,2019,21(11): 1299-1305. DOI:10.1002/ejhf.1611.
[24] K I T S U T , K A B A S A W A K , I T O Y , e t a l . L o w s e r u m 25-hydroxyvitamin D is associated with low grip strength in an older Japanese population[J]. J Bone Miner Metab,2020,38(2): 198-204. DOI:10.1007/s00774-019-01040-w.
[25] CEGLIA L,HARRIS S S.Vitamin D and its role in skeletal muscle[J]. Calcif Tissue Int,2013,92(2):151-162. DOI: 10.1007/s00223-012-9645-y.
[26] CESARI M,KRITCHEVSKY S B,NICKLAS B,et al. Oxidative damage,platelet activation,and inflammation to predict mobility disability and mortality in older persons:results from the health aging and body composition study[J]. J Gerontol A Biol Sci Med Sci,2012,67(6):671-676. DOI:10.1093/gerona/glr246.
[27] TIAINEN K,HURME M,HERVONEN A,et al. Inflammatory markers and physical performance among nonagenarians[J]. J Gerontol A Biol Sci Med Sci,2010,65(6):658-663. DOI: 10.1093/gerona/glq056.
[28] MA L N,SHA G M,ZHANG Y X,et al. Elevated serum IL-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults[J]. Clin Interv Aging,2018,13:2013- 2020. DOI:10.2147/CIA.S180934.
[29] BRUYÈRE O,CAVALIER E,BUCKINX F,et al. Relevance of vitamin D in the pathogenesis and therapy of frailty[J]. Curr Opin Clin Nutr Metab Care,2017,20(1):26-29. DOI: 10.1097/MCO.0000000000000334.
[30] PARTAN R U,HIDAYAT R,SAPUTRA N,et al. Seluang fish (Rasbora spp.) oil decreases inflammatory cytokines via increasing vitamin D level in systemic lupus erythematosus[J].Open Access Maced J Med Sci,2019,7(9):1418-1421. DOI:10.3889/oamjms.2019.308.
[31] MOTAMED S,NIKOOYEH B,KASHANIAN M,et al. Efficacy of two different doses of oral vitamin D supplementation on inflammatory biomarkers and maternal and neonatal outcomes[J]. Matern Child Nutr,2019,15(4):e12867. DOI:10.1111/mcn.12867.
[32] VANHERWEGEN A S,GYSEMANS C,MATHIEU C.Vitamin D endocrinology on the cross-road between immunity and metabolism[J]. Mol Cell Endocrinol,2017,453:52-67. DOI:10.1016/j.mce.2017.04.018.
[33] POJEDNIC R M,CEGLIA L.The emerging biomolecular role of vitamin D in skeletal muscle[J]. Exerc Sport Sci Rev,2014,42 (2):76-81. DOI:10.1249/JES.0000000000000013.
[34] BISCHOFF-FERRARI H A,ORAV E J,ABDERHALDEN L, et al. Vitamin D supplementation and musculoskeletal health[J]. Lancet Diabetes Endocrinol,2019,7(2):85. DOI:10.1016/ s2213-8587(18)30347-4.
[35] WEAVER C M,ALEXANDER D D,BOUSHEY C J,et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation[J]. Osteoporos Int,2016,27(1):367-376. DOI:10.1007/s00198-015-3386-5.
[36] MURAD M H,ELAMIN K B,ABU ELNOUR N O,et al. Clinical review:the effect of vitamin D on Falls:a systematic review and meta-analysis[J]. J Clin Endocrinol Metab,2011,96(10): 2997-3006. DOI:10.1210/jc.2011-1193.
[37] BEAUDART C,BUCKINX F,RABENDA V,et al. The effects of vitamin D on skeletal muscle strength,muscle mass,and muscle power:a systematic review and meta-analysis of randomized controlled trials[J]. J Clin Endocrinol Metab,2014,99(11): 4336-4345. DOI:10.1210/jc.2014-1742.
[38] REMELLI F,VITALI A,ZURLO A,et al. Vitamin D deficiency and sarcopenia in older persons[J]. Nutrients,2019,11(12): E2861. DOI:10.3390/nu11122861.
[39] SELDEEN K L,BERMAN R N,PANG M H,et al. Vitamin D insufficiency reduces grip strength,grip endurance and increases frailty in aged C57Bl/6J mice[J]. Nutrients,2020,12(10): E3005. DOI:10.3390/nu12103005.
[40] CUMMINGS S R,KIEL D P,BLACK D M.Vitamin D supplementation and increased risk of falling:a cautionary tale of vitamin supplements retold[J]. JAMA Intern Med,2016,176(2): 171-172. DOI:10.1001/jamainternmed.2015.7568.
[41] Dietary reference intakes for calcium and vitamin D[M]. Washington,D.C.:National Academies Press,2011.
[42] HOLICK M F,BINKLEY N C,BISCHOFF-FERRARI H A,et al. Evaluation,treatment,and prevention of vitamin D deficiency:an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab,2011,96(7):1911-1930. DOI:10.1210/jc.2011- 0385.
Enteral nutrition (EN) is one important clinical treatment for severe acute pancreatitis (SAP) , but the optimal timing of initiation remains controversial.
To evaluate the efficacy of EN within 24 hours of admission in the treatment of SAP by applying a Meta-analysis.
Databases of PubMed, EMBase, the Cochrane Library, Web of Science, CNKI, VIP, Wanfang Data and SinoMed were searched to identify randomized controlled trials (RCTs) about efficacies of usual care and EN within 24 hours of admission (experimental group) versus usual care in combination with EN or oral eating after 24 hours of admission or parenteral nutrition immediately after admission (control group) in SAP patients included from inception to July 2021. Meta-analysis was performed using RevMan 5.4 software.
A total of 13 RCTs involving 1 193 patients were included. Meta-analysis results revealed that, compared to usual care with control interventions, usual care with EN within 24 hours of admission had better effects on reducing the mortality〔RR=0.61, 95%CI (0.39, 0.95) , P=0.03〕, incidence of multiple organ dysfunction syndrome (MODS) 〔RR=0.56, 95%CI (0.36, 0.86) , P=0.009〕and incidence of pancreatic infections〔RR=0.55, 95%CI (0.33, 0.91) , P=0.02〕, and post-treatment APACHE Ⅱ score〔MD=-2.18, 95%CI (-2.55, -1.80) , P<0.000 01〕. Further subgroup analysis indicated that, usual care with EN within 24 hours of admission was superior to usual care with parenteral nutrition immediately after admission in decreasing the mortality〔RR=0.28, 95%CI (0.11, 0.73) , P=0.009〕, incidence of MODS〔RR=0.40, 95%CI (0.20, 0.79) , P=0.009〕and pancreatic infections〔RR=0.50, 95%CI (0.25, 0.98) , P=0.04〕.
Available evidence showed that, EN within 24 hours of admission had better efficacy for SAP, and initiating EN within 24 hours of admission may be beneficial to the treatment of SAP.
The prevalence of comorbidity in the elderly is showing a rising trend year by year with the acceleration of population aging. Comorbidity is a key risk factor for frailty in the elderly. Then frailty only increases the risk of adverse health outcomes for patients with comorbidity, but also significantly increases their family medical expenses. It has a certain guiding value for the management of comorbidity to identify the frailty conditions of elderly patients with comorbidity as early as possible.
To systematically review the prevalence of frailty in elderly patients with comorbidity.
CNKI, VIP, CBM, WanFang, PubMed, EmBase, Web of Science and Cochrane Library were searched in December 2021 for the investigation studies on the current status of frailty in elderly patients with comorbidity published from inception to December 4, 2021. Two researchers performed literature screening and data extraction independently. The cross-sectional study quality rating scale and Newcastle-Ottawa Scale (NOS) recommended by Agency for Healthcare Research and Quality (AHRQ) were used to assess the risk of bias of the included studies and Stata 14.0 was adopted for meta-analysis.
A total of 25 studies involving 16 062 elderly patients with comorbidity were included. Meta-analysis results showed that the prevalence of frailty and pre-frailty in elderly patients with comorbidity was 26.7%〔95%CI (21.9%, 31.5%) 〕and 47.7%〔95%CI (43.9%, 51.4%) 〕. Subgroup analysis showed that the prevalence of frailty in older adults with≥2, ≥3, ≥4, and≥5 chronic diseases was 25.1%〔95%CI (19.3%, 30.8%) 〕, 27.4%〔95%CI (13.7%, 41.0%) 〕, 60.7%〔95%CI (29.0%, 92.4%) 〕, and 23.5%〔95%CI (8.6%, 38.5%) 〕, respectively. The prevalence of frailty in elderly patients with comorbidity in Oceania (52.1%) and Asia (31.3%) were significantly higher than Europe (16.9%) and South America (13.2%) . The prevalence of frailty in elderly patients with comorbidity in hospital (26.2%) was significantly higher than community (23.2%) . The prevalence of frailty in elderly patients with comorbidity screened by Clinical Frailty Scale (CFS) , Fried frailty phenotype scale and FRAIL Scale was 42.8%〔95%CI (38.4%, 47.1%) 〕, 22.2%〔95%CI (17.8%, 26.7%) 〕and 8.5%〔95%CI (6.3%, 10.6%) 〕, respectively. The prevalence of frailty in elderly patients surveyed in 2001—2010, 2011—2015, and 2016—2020 was 21.0%〔95%CI (13.2%, 28.8%) 〕, 19.0%〔95%CI (13.1%, 24.8%) 〕and 37.7%〔95%CI (22.6%, 52.9%) 〕, respectively.
The prevalence of frailty in elderly patients with comorbidity is gradually increasing, with differences by number of co-morbidities, continents, assessment tools and study sites. Therefore, relevant personnel should pay attention to early screening of frailty in elderly patients with comorbidity and take timely measures to prevent the development of frailty in elderly patients with comorbidity.